<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">NPJ Biofilms Microbiomes</journal-id><journal-id journal-id-type="iso-abbrev">NPJ Biofilms Microbiomes</journal-id><journal-id journal-id-type="pmc-domain-id">3133</journal-id><journal-id journal-id-type="pmc-domain">npjbiofilms</journal-id><journal-title-group><journal-title>NPJ Biofilms and Microbiomes</journal-title></journal-title-group><issn pub-type="epub">2055-5008</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12475442</article-id><article-id pub-id-type="pmcid-ver">PMC12475442.1</article-id><article-id pub-id-type="pmcaid">12475442</article-id><article-id pub-id-type="pmcaiid">12475442</article-id><article-id pub-id-type="pmid">41006302</article-id><article-id pub-id-type="doi">10.1038/s41522-025-00754-2</article-id><article-id pub-id-type="publisher-id">754</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Characterizing interactions of <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Escherichia coli</italic> in dual-species implant-associated biofilms</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sekar</surname><given-names initials="A">Amita</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ben Malick</surname><given-names initials="F">Fawaz</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Deepak</surname><given-names initials="SU">Shweta Uma</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Inverardi</surname><given-names initials="N">Nicoletta</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Murugesan</surname><given-names initials="D">Dillon</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Muratoglu</surname><given-names initials="OK">Orhun K.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Oral</surname><given-names initials="E">Ebru</given-names></name><address><email>eoral@mgh.harvard.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/002pd6e78</institution-id><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution>Harris Orthopaedics Laboratory, </institution><institution>Massachusetts General Hospital, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03vek6s52</institution-id><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Orthopaedic Surgery, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>11</volume><issue-id pub-id-type="pmc-issue-id">478289</issue-id><elocation-id>189</elocation-id><history><date date-type="received"><day>5</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>5</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 18:25:14.327"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41522_2025_Article_754.pdf"/><abstract id="Abs1"><p id="Par1">While <italic toggle="yes">Staphylococcus aureus</italic> is the predominant pathogen in periprosthetic joint infections (PJI), polymicrobial infections involving Gram-negative organisms, such as <italic toggle="yes">Escherichia coli</italic>, complicate clinical outcomes. Little is known regarding implant-associated polymicrobial interactions; consequently, current PJI treatments are not optimized for their treatment. This study explored the dynamics of <italic toggle="yes">S. aureus-E. coli</italic> dual-species biofilms, focusing on biofilm properties, antibiotic susceptibility, and molecular interactions. Co-culture experiments revealed that <italic toggle="yes">E. coli</italic> significantly suppressed <italic toggle="yes">S. aureus</italic> biofilm viability, observed for methicillin-susceptible <italic toggle="yes">S. aureus</italic> (MSSA) and methicillin-resistant <italic toggle="yes">S. aureus</italic> (MRSA). Microscopic analyses demonstrated enhanced <italic toggle="yes">E. coli</italic> attachment facilitated by <italic toggle="yes">S. aureus</italic> matrix proteins; however, over time, <italic toggle="yes">E. coli</italic> dominated the biofilm composition. In the presence of <italic toggle="yes">E. coli</italic>, MSSA biofilm exhibited improved gentamicin susceptibility while MRSA showed limited change, underscoring strain-specific interactions. Notably, <italic toggle="yes">E. coli</italic> biofilms exhibited enhanced resistance to gentamicin in dual-species settings. Gene expression profiling revealed molecular adaptation in <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic>, triggered by the differential regulation of stress, adhesion, virulence, and biofilm-associated genes within a dual-species implant-associated biofilm. The suppression of <italic toggle="yes">S. aureus</italic> by <italic toggle="yes">E. coli</italic> presents potential therapeutic avenues, and in vivo studies and mechanistic investigations are crucial for optimizing treatment strategies targeting polymicrobial PJIs.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Microbiology</kwd><kwd>Health care</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AR077023</award-id><award-id>R01AR077023</award-id><award-id>R01AR077023</award-id><award-id>R01AR077023</award-id><award-id>R01AR077023</award-id><award-id>R01AR077023</award-id><award-id>R01AR077023</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Total joint arthroplasties (TJA), prescribed for end-stage arthritis, offer an improved quality of life for &gt;1 million patients annually, who undergo this procedure<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Periprosthetic joint infection (PJI), which affects approximately 2% of patients, is the most severe complication associated with TJA, greatly impacting patients&#8217; well-being due to its high morbidity and mortality rates<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Revision surgery to remove infected tissues and replace infected prosthesis components, followed by local and systemic antibiotic administration, remains the recommended treatment strategy to manage PJI<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. However, infection remains one of the primary causes of revision failure rates, resulting in poor outcomes<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p><p id="Par3">Approximately 6-40% of PJI are diagnosed as polymicrobial, with more than one causative organism<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. In PJI, polymicrobial infections are frequent in early postoperative PJI (&#8201;~&#8201;30%) and patients with polymicrobial PJI are at higher risk for complications, with &gt;70% of cases resulting in unsuccessful outcomes<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. In clinical settings, two or more infecting microorganisms have been frequently isolated, harboring varying antibiotic resistance profiles, which pose a critical treatment challenge<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. The cohabitation within a polymicrobial biofilm further increases the probability of antibiotic resistance gene transfer, resulting in a high-risk multidrug-resistant infection<sup><xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR14">14</xref></sup>. PJI is diagnosed definitively only by using the culture of tissue debrided in open surgery<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. While this is the standard, negative culture incidence is approximately 20%, highlighting the limitations of ex vivo culture due to prior antibiotic usage and improper diagnostic workup<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. For polymicrobial infections, competitive inhibition exhibited by the involved microorganisms is a crucial determinant for accurate identification, which results in further underestimation of their incidence<sup><xref ref-type="bibr" rid="CR17">17</xref></sup><sup>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. The high prevalence of polymicrobial PJI warrants the study of multispecies infection dynamics and interactions.</p><p id="Par4"><italic toggle="yes">S. aureus</italic> and other coagulase-negative staphylococci (CoNS) are the predominant organisms that account for &gt;60&#8211;70% of PJI<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Acute infections, that occur postoperatively &lt;3 months are majorly caused by <italic toggle="yes">S. aureus</italic> (20&#8211;40%) spreading from surgical site contamination<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. The high incidence could be attributed to their capability to thrive in hypoxic environments such as that of joint space<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. Staphylococci can exist as aggregates in vivo<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, and joint synovial fluid further promotes the formation of a proteinaceous matrix surrounding them<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. These microbial aggregates utilize adhesins (MSCRAMMs, elastin, and fibronectin-binding proteins) and polysaccharide matrix (polysaccharide intercellular adhesins) to attach to implant materials and surrounding tissue, embedding microbial communities extensively over time, thereby establishing a biofilm<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. <italic toggle="yes">S. aureus</italic> biofilms produce specific virulence factors such as leukocidins and other small molecule inhibitors to interfere with host responses and modulate their responses to evade detection and promote survival<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. In PJI, the avascular surfaces of implantable materials make the host more prone to infections<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, but their role in the evolution of infectious communities is not well understood. To date, <italic toggle="yes">S. aureus</italic> has been reported in three distinct biofilm reservoirs within the implant, joint, and bone environments<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. The complex biofilm dynamics in the presence of implant materials further impart physical and chemical barriers against antibiotic treatments (antibiotic tolerance) rendering them incapable of eradicating PJI. Besides, there is a compounded risk associated with the increasing prevalence of methicillin and vancomycin-resistant <italic toggle="yes">S. aureus</italic> (MRSA/VRSA) in PJI<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. Consequently, to combat antibiotic resistance and biofilm-associated antibiotic tolerance, a cocktail of antibiotics at high local concentrations (&gt;100&#215; MIC) are often necessary in efforts to tackle PJI<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>.</p><p id="Par5">Current treatment strategies for suspected polymicrobial PJI involve systemic and local dosing of broad-spectrum beta-lactam antibiotics and aminoglycosides, which are not optimized to eradicate polymicrobial biofilms<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>. Gentamicin, specifically, remains integral to current local approaches such as bone cement and spacers in the clinic, bolstering systemic antibiotic strategies to prevent the recurrence of PJI<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. To improve the translational value of drug-eluting implant materials for polymicrobial PJI prophylaxis, an in-depth understanding of implant-associated polymicrobial dynamics is warranted to effectively prevent PJI while curbing the poor outcomes associated with multidrug resistance.</p><p id="Par6"><italic toggle="yes">S. aureus</italic> is also the most isolated organism in polymicrobial PJI (~56%)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, highly capable of co-forming multi-species biofilms. The presence of more than one organism creates a unique competitive microenvironment that regulates the growth, antibiotic susceptibility, and physiology of the bacteria<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. Among microorganisms, Gram-negative bacteria commonly harbor multi-drug resistance, and their combination with MRSA/VRSA in a polymicrobial setting tremendously increases the risk and severity of PJI<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. Studies have shown <italic toggle="yes">S. aureus</italic> frequently isolated with Gram-negative <italic toggle="yes">E. coli</italic> and <italic toggle="yes">Pseudomonas aeruginosa</italic>, wherein they often have a negative or synergistic impact on the growth and antibiotic susceptibility of <italic toggle="yes">S. aureus</italic><sup><xref ref-type="bibr" rid="CR41">41</xref>&#8211;<xref ref-type="bibr" rid="CR44">44</xref></sup>. Recent reports have identified a significant impact of polymicrobial interactions on microbial viability, colonization, and immune evasion properties of <italic toggle="yes">S. aureus</italic> in catheter-associated infections<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. These reports strongly suggest that polymicrobial interactions regulate physiological processes, promote genetic exchange conferring antibiotic resistance, and form complex biofilm matrices. These should be specifically studied in the context of PJI.</p><p id="Par7">The international consensus meeting on musculoskeletal infection<sup><xref ref-type="bibr" rid="CR47">47</xref>&#8211;<xref ref-type="bibr" rid="CR50">50</xref></sup> has identified polymicrobial infections as a vital understudied area. Our study aims to address this knowledge gap by focusing on the behavior of <italic toggle="yes">S. aureus</italic> in a polymicrobial infection with <italic toggle="yes">E. coli</italic> due to its oversized impact on the prevalence and outcomes of PJI.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title><italic toggle="yes">E. coli</italic> affects the implant-associated biofilm growth dynamics of <italic toggle="yes">S. aureus</italic></title><p id="Par8">The biofilm dynamics of <italic toggle="yes">S. aureus</italic> (MSSA, MRSA) and <italic toggle="yes">E. coli</italic> (EC) during their coexistence in a dual-species implant-associated setting were determined over 48&#8201;h. Our previous study determined 6-h and 24-hour-grown biofilms as &#8220;nascent&#8221; and &#8220;established&#8221; biofilms, respectively<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. In dual-species biofilms, the implant-adhered viable bacteria for MSSA were significantly reduced (&gt;3&#8201;log) at 6 and 24&#8201;h in the presence of EC when compared to its mono-species control (<italic toggle="yes">p</italic>value&#8201;=&#8201;0.03120 (6&#8201;h); 0.0004491 (24&#8201;h)). By 48&#8201;h, the adherent biofilm viability for MSSA was below the detection limit in dual-species implant-adhered biofilm culture (<italic toggle="yes">p</italic>value&#8201;=&#8201;0.0075) in contrast to that of the control, which demonstrated a highly viable implant-associated biofilm. For EC, no change in biofilm viability was observed in a dual-species biofilm compared to that of the control EC over the same period.</p><p id="Par9">In MRSA and EC dual-species biofilms, MRSA viability at 6&#8201;h was increased compared to the control MRSA biofilm (<italic toggle="yes">p</italic>value&#8201;=&#8201;0.0126). By 24&#8201;h, MRSA&#8217;s adherent biofilm viability was significantly reduced and below the detection limit in the presence of EC compared to that of the control MRSA (<italic toggle="yes">p</italic>value&#8201;=&#8201;0.00076). At 48&#8201;h, the viability of MRSA was above the detection limit but significantly reduced compared to MRSA biofilm control (<italic toggle="yes">p</italic>value&#8201;=&#8201;0.0217). The adherent biofilm viability of EC was not altered compared to control EC over the same timeframe (Fig. <xref rid="Fig1" ref-type="fig">1a, b</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title><italic toggle="yes">E. coli</italic> affects the implant-associated biofilm growth dynamics of <italic toggle="yes">S. aureus</italic>.</title><p>Bacterial viability quantified for (<bold>a</bold>) MSSA and EC, <bold>b</bold> MRSA and EC in an implant-associated polymicrobial biofilm cultured for 6-, 24-, and 48-h using the plate count method (<italic toggle="yes">n</italic>&#8201;=&#8201;6) and fluorescent Gram staining. The error bars in bar charts represent the standard deviation, and an unpaired, one-tailed, and unequal variance student <italic toggle="yes">t</italic> test was performed. The percentage of syto9/hexidium iodide stain indicating SA and EC viability, respectively, was quantified and represented as a pie chart (<italic toggle="yes">n</italic>&#8201;=&#8201;10 fields/condition). <bold>c</bold> Representative images of Mannitol salt and MacConkey agar plates depicting the colony morphology of SA and EC colonies recovered from polymicrobial biofilm. The images demonstrate the small colony variants (SCVs) occurrence and changes in colony color for SA in Mannitol salt and EC in MacConkey agar, respectively. The colony morphology of viable SA and EC from mono-microbial biofilms served as control.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e569" position="float" orientation="portrait" xlink:href="41522_2025_754_Fig1_HTML.jpg"/></fig></p><p id="Par10">Semiquantitative fluorescent Gram staining demonstrated the percentage of viable bacteria recovered from a dual-species implant-associated biofilm for MSSA, MRSA, and EC (Fig. <xref rid="Fig1" ref-type="fig">1a, b</xref>). The viability of MSSA was decreased from 78% to 14% by 48&#8201;h, and the viability of MRSA was reduced from 29% to 2% over the same time in the presence of EC. The viable EC recovered increased from 22 to 86% and from 71 to 98% over 48&#8201;h in the presence of MSSA and MRSA, respectively. In the dual-species setting, the recovered viable MSSA and MRSA from 6, 24, and 48&#8201;h dual-species biofilms, plated on selective agar plates, demonstrated white SCVs, (&lt;0.4&#8201;mm) in mannitol salt agar compared to yellow normal-sized SA colonies (1-4&#8201;mm) from control mono-species biofilms. On the other hand, the viable EC showed more colorless colonies with corrugated morphology in MacConkey agar compared to mauve, entire colonies from the control mono-species biofilm (Fig. <xref rid="Fig1" ref-type="fig">1c</xref>).</p></sec><sec id="Sec4"><title>Dual microbial interactions influence the implant-associated biofilm properties</title><p id="Par11">The viable SA and EC within the dual-species implant-associated biofilm were confirmed by fluorescent microscopy (Fig. <xref rid="Fig2" ref-type="fig">2a</xref>). At 6&#8201;h, increased adhesion and colonization of SA were observed compared to EC. Cohabitation of viable SA and EC was observed after 24&#8201;h of biofilm growth, with clusters of SA and EC forming adherent aggregates. Evidently, within 48&#8201;h, viable EC biofilms dominantly adhered to the SS plates compared to SA.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>Dual microbial interactions influence the implant-associated biofilm properties.</title><p><bold>a</bold> Fluorescent micrographs of syto9-stained polymicrobial biofilms (6, 24, and 48&#8201;h) on stainless-steel implant material. Scale bars,10&#8201;&#181;m. White arrows indicate the cohabitation of SA cocci and EC rods. <bold>b</bold> Scanning electron micrographs of polymicrobial and monomicrobial biofilms (6, 24, and 48&#8201;h) grown on stainless-steel implant material (<italic toggle="yes">n</italic>&#8201;=&#8201;3). Imaging parameters: 1.5&#8211;3&#8201;kV; magnification, 2, 5, and 10 KX; scale bars, 5, 2, and 1&#8201;&#181;m; working distance (WD)&#8201;~&#8201;6.5&#8201;mm. Red arrows indicate intact SA aggregates; pink arrows indicate deflated SA aggregates; dark blue arrows indicate EC and light blue arrows indicate furrowed EC in the presence of SA.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e601" position="float" orientation="portrait" xlink:href="41522_2025_754_Fig2_HTML.jpg"/></fig></p><p id="Par12">MSSA/MRSA and EC cohabitation on the implant material was visualized in detail using scanning electron microscopy at 6, 24, and 48&#8201;h (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). For the biofilms containing MSSA and EC, SEM revealed the substantial presence of both species at 6&#8201;h. The number of attached EC was visibly less at 6&#8201;h than the monomicrobial EC biofilm. The adhered MSSA and EC in dual-species biofilm were noticeably viable due to the intact cell walls observed for the spherical SA aggregates and interconnected EC rods, respectively. MSSA and EC mono-species controls demonstrated significant adhesion and propagation of viable biofilm on the implant materials at 6&#8201;h. For the biofilms of MRSA and EC, the number of attached MRSA was visibly less than that of EC at 6&#8201;h. The pockets of intact spherical aggregates of MRSA were found surrounded by many adhered EC.</p><p id="Par13">After 24&#8201;h, there was a somewhat equal proportion of MSSA and EC adhered, with noticeably deflated spheres for MSSA. The proportion of viable MRSA was significantly reduced (as indicated by their sparsity) in the presence of EC. On the other hand, EC demonstrated biofilm formation in the presence of both MSSA and MRSA, comparable to its mono-species biofilm at 24&#8201;h. EC developed extensive chain-like growth features in the dual-species biofilm with SA cells attached to the EC biofilm matrix and/or cell surface (Fig. <xref rid="Fig2" ref-type="fig">2b</xref>). EC appeared to have undergone morphological changes (less pronounced biofilm sheath) in the presence of SA compared to their mono-species biofilms (prominent biofilm sheath).</p><p id="Par14">At 48&#8201;h, only a few MSSA and MRSA aggregates were observed with EC compared to their respective mono-species biofilms, which showed significant colonization. Shortened rods of EC were observed in the presence of MSSA. With MRSA, EC appeared furrowed despite increased adhesion. Overall, more biofilm formation was observed for EC in the presence of SA compared to that of its monomicrobial biofilm (porous cell morphology and sparse adhesion).</p></sec><sec id="Sec5"><title><italic toggle="yes">E. coli</italic> alters the gentamicin susceptibility of <italic toggle="yes">S. aureus</italic> in implant-associated biofilms</title><p id="Par15">The MIC and MBC of gentamicin for MSSA (0.5 and 2&#8201;&#181;g/mL), MRSA (&gt;128 and &gt;256&#8201;&#181;g/mL), EC (0.25 and 4&#8201;&#181;g/mL) were determined using the micro broth dilution assay. The gentamicin concentration that resulted in &gt;3-log reduction in biofilm viability (MBEC) for MSSA and MRSA in the presence of EC was determined for nascent (6&#8201;h) and established (24 and 48&#8201;h) biofilms (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). In the presence of EC, the MBEC of gentamicin for MSSA was significantly reduced for nascent and established biofilms (&lt;10&#8211;25&#8201;&#181;g/mL) when compared to the MBEC for MSSA in a mono-species biofilm (100&#8211;500&#8201;&#181;g/mL) (<italic toggle="yes">p</italic>value&#8201;=&#8201;0.0076 (6&#8201;h); 0.0067 (24&#8201;h)). The MBEC of gentamicin for EC increased in dual-species biofilms with MSSA for nascent (&lt;100&#8201;&#181;g/mL) and 24-h established biofilms (&lt;500&#8201;&#181;g/mL) when compared to their monomicrobial biofilms (&lt;25&#8211;50&#8201;&#181;g/mL) (Fig. <xref rid="Fig3" ref-type="fig">3a</xref>).<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title><italic toggle="yes">E. coli</italic> alters the gentamicin susceptibility of <italic toggle="yes">S. aureus</italic> in implant-associated biofilms.</title><p>Heatmaps depicting viable bacterial count (CFU/mL) for (<bold>a</bold>) MSSA and EC, <bold>b</bold> MRSA and EC recovered from implant-associated polymicrobial and monomicrobial biofilms exposed to indicated gentamicin concentrations. The data are representative of three independent experiments (<italic toggle="yes">n</italic>&#8201;=&#8201;2/drug exposure per experiment).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e656" position="float" orientation="portrait" xlink:href="41522_2025_754_Fig3_HTML.jpg"/></fig></p><p id="Par16">For MRSA in a dual-species biofilm, no significant difference in MBEC was observed for nascent (6&#8201;h) and established (24&#8201;h) biofilms compared to the mono-species control. For the 48-h biofilms, the MBEC required for &gt;3-log reduction of MRSA was reduced from &gt;500&#8201;&#181;g/mL to 200&#8211;500&#8201;&#181;g/mL in the presence of EC. The MBEC of gentamicin for EC in dual-species biofilm was consistent (&lt;75&#8201;&#181;g/mL) at all indicated time points when compared to the monomicrobial biofilm that showed biofilm-maturity-associated increase in the MBEC (&gt;500&#8201;&#181;g/mL for 48-h established biofilms) (Fig. <xref rid="Fig3" ref-type="fig">3b</xref>).</p></sec><sec id="Sec6"><title><italic toggle="yes">S</italic><italic toggle="yes">. aureus</italic> and <italic toggle="yes">E</italic><italic toggle="yes">. coli</italic> mutually regulate molecular events in an implant-associated polymicrobial setting</title><p id="Par17">Biofilm gene expression of MSSA, MRSA, and EC in nascent (6&#8201;h) and established (24&#8201;h) dual and mono-species implant-associated biofilms was determined. For SA, <italic toggle="yes">vraR</italic> (peptidoglycan biosynthesis), <italic toggle="yes">sigB</italic> (sigma factor, stress response regulator), <italic toggle="yes">yjbH</italic> (virulence and oxidative stress response regulator), <italic toggle="yes">icaA</italic> and <italic toggle="yes">icaD</italic> (intercellular adhesin proteins), <italic toggle="yes">agrA</italic> (quorum sensing, virulence regulator), <italic toggle="yes">spa</italic> (Protein A), <italic toggle="yes">atl</italic> (autolysin), <italic toggle="yes">clfA</italic> (clumping factor A) and <italic toggle="yes">sarA</italic> (transcriptional regulator) gene expression were determined. For EC, <italic toggle="yes">lacZ</italic> (lactose metabolism), <italic toggle="yes">tomB</italic> (biofilm formation, hemolysin toxicity regulator), <italic toggle="yes">sdiA</italic> (quorum sensing regulator), <italic toggle="yes">gyrA</italic> (DNA metabolism, transcription regulator), <italic toggle="yes">clbA</italic> and <italic toggle="yes">clbB</italic> (Colibactin toxin), and <italic toggle="yes">rpoS</italic> (stress response regulator) gene expression were determined. In dual-species nascent (6-h) biofilms, MSSA demonstrated increased expression for all genes except <italic toggle="yes">sarA</italic> compared to the control. On the other hand, MRSA demonstrated significant downregulation for all genes except <italic toggle="yes">sarA</italic> in the presence of EC compared to its control biofilm. The expression of <italic toggle="yes">vraR</italic>, <italic toggle="yes">clfA</italic>, <italic toggle="yes">sarA</italic>, <italic toggle="yes">yjbH</italic>, <italic toggle="yes">sigB</italic>, <italic toggle="yes">icaA</italic>, <italic toggle="yes">icaD</italic>, <italic toggle="yes">atl</italic>, and <italic toggle="yes">agrA</italic> genes was significantly downregulated in MRSA when compared to that of MSSA in the presence of EC. In an established (24-h) dual-species biofilm, the gene expression was downregulated overall for all MSSA genes, except for <italic toggle="yes">sarA</italic>, demonstrating increased expression. The <italic toggle="yes">spa</italic> gene was found to be somewhat elevated in MSSA. For MRSA, <italic toggle="yes">yjbH</italic>, <italic toggle="yes">atl</italic>, and <italic toggle="yes">clfA</italic> were significantly upregulated, and the genes <italic toggle="yes">vraR</italic> and <italic toggle="yes">spa</italic> were downregulated in the presence of EC compared to their respective controls. The expression of <italic toggle="yes">vraR</italic>, <italic toggle="yes">clfA</italic>, <italic toggle="yes">sarA</italic>, <italic toggle="yes">yjbH</italic>, <italic toggle="yes">sigB</italic>, <italic toggle="yes">icaA</italic>, <italic toggle="yes">icaD</italic>, <italic toggle="yes">atl</italic>, and <italic toggle="yes">agrA</italic> genes was significantly upregulated in MRSA when compared to that of MSSA in the presence of EC (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>).<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><title>SA and EC mutually regulate molecular events in an implant-associated polymicrobial setting.</title><p>Gene expression profiles of (<bold>a</bold>) MSSA and MRSA, <bold>b</bold> EC in dual and mono-species implant-associated biofilms. <bold>c</bold> Gene expression profile of MSSA and MRSA exposed to sub-MBEC of gentamicin in dual and mono-species biofilms. The expression of SA genes (<italic toggle="yes">vraR</italic>, <italic toggle="yes">sigB</italic>, <italic toggle="yes">yjbH</italic>, <italic toggle="yes">agrA</italic>, <italic toggle="yes">icaA, icaD, atl, spa, sarA, and clfA</italic>) and EC genes <italic toggle="yes">(clbA</italic>, <italic toggle="yes">clbB</italic>, <italic toggle="yes">lacZ</italic>, <italic toggle="yes">tomB</italic>, <italic toggle="yes">rpoS</italic>, <italic toggle="yes">gyrA</italic> and <italic toggle="yes">sdiA</italic>) was normalized to their respective <italic toggle="yes">16srRNA</italic> and fold change 2<sup>(-&#916;Cq)</sup> determined. Error bars indicate standard deviation (<italic toggle="yes">n</italic>&#8201;=&#8201;3); * indicates <italic toggle="yes">p</italic>value&#8201;&lt;&#8201;0.05. (Welch&#8217;s <italic toggle="yes">t</italic>test).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e888" position="float" orientation="portrait" xlink:href="41522_2025_754_Fig4_HTML.jpg"/></fig></p><p id="Par18">In dual-species, nascent biofilms (6-h), <italic toggle="yes">lacZ</italic>, <italic toggle="yes">sdiA, tomB, gyrA, and</italic> colibactin-toxin-associated genes (<italic toggle="yes">clbA</italic>, <italic toggle="yes">clbB</italic>) gene expression in EC were significantly upregulated by MSSA. In the presence of MRSA, all the genes tested were upregulated in EC compared to the respective control biofilms. The expression of all genes was significantly higher in the presence of MRSA than in MSSA. In dual-species established biofilms (24-h), all genes were downregulated in the presence of MSSA except for <italic toggle="yes">tomB</italic>, which stayed upregulated compared to the mono-species EC control biofilm. In the presence of MRSA, EC gene expression remained unaltered except for <italic toggle="yes">tomB</italic>, which was significantly downregulated (Fig. <xref rid="Fig4" ref-type="fig">4b</xref>). Compared to MSSA, all genes&#8217; expression was markedly higher in the presence of MRSA, except for <italic toggle="yes">tomB</italic>, which was downregulated in EC.</p><p id="Par19">The effects of sub-MBEC gentamicin exposure and the presence of EC on the microbial physiology of <italic toggle="yes">S. aureus</italic> in dual-species biofilms were determined. For the dual-species nascent biofilms, MSSA in the presence of EC and gentamicin demonstrated a notable upregulation for the genes <italic toggle="yes">vraR, yjbH, sigB, agrA, icaA</italic>, and <italic toggle="yes">icaD</italic> and downregulation for the gene <italic toggle="yes">spa</italic> compared to the MSSA mono-species control. On the other hand, for MRSA, the expression for all genes except <italic toggle="yes">atl</italic> was significantly downregulated, compared to the MRSA mono-species control. The expression of <italic toggle="yes">spa</italic>, <italic toggle="yes">clfA</italic>, <italic toggle="yes">sarA</italic>, <italic toggle="yes">yjbH</italic>, <italic toggle="yes">sigB</italic>, <italic toggle="yes">icaA</italic>, and <italic toggle="yes">icaD</italic> genes was significantly higher in MRSA when compared to that of MSSA in the presence of EC and gentamicin. In dual-species established biofilms, <italic toggle="yes">vraR</italic>, <italic toggle="yes">yjbH</italic>, <italic toggle="yes">sigB</italic>, <italic toggle="yes">agrA</italic>, <italic toggle="yes">icaA</italic>, <italic toggle="yes">icaD</italic>, <italic toggle="yes">and atl</italic> gene expression were significantly upregulated in MSSA, while <italic toggle="yes">clfA</italic> and <italic toggle="yes">sarA</italic> were downregulated. In MRSA, all genes were upregulated in the presence of EC and gentamicin except <italic toggle="yes">spa</italic>, which was significantly downregulated. The expression of <italic toggle="yes">yjbH</italic>, <italic toggle="yes">sigB</italic>, <italic toggle="yes">icaA</italic>, <italic toggle="yes">and icaD</italic> was upregulated considerably in MRSA compared to MSSA, while <italic toggle="yes">atl</italic>, <italic toggle="yes">clfA</italic>, and <italic toggle="yes">sarA</italic> genes were downregulated (Fig. <xref rid="Fig4" ref-type="fig">4c</xref>).</p></sec></sec><sec id="Sec7" sec-type="discussion"><title>Discussion</title><p id="Par20">PJI is a morbid condition associated with total joint arthroplasty that endangers the joint function and longevity of millions of patients<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Polymicrobial PJI (involving more than one organism) presents a substantial fraction of PJI cases<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Although clinical studies have pointed to the causal relationship between polymicrobial PJI and poor treatment outcomes, the implant-associated polymicrobial interactions within biofilms and their physiological properties has not been studied. <italic toggle="yes">S. aureus</italic> is the most common microorganism in mono- and polymicrobial PJI; most PJI cases would benefit from describing its infection dynamics and focusing treatment strategies targeting it. Our study focuses on polymicrobial interactions in the context of PJI, focusing on how <italic toggle="yes">S. aureus</italic> pathogenesis for implant-associated infection is affected by the presence of <italic toggle="yes">E. coli</italic>.</p><p id="Par21">The definition and characterization of biofilm associated with medical devices are still in their infancy, with challenges in harmonizing the state of infections in vitro and in vivo<sup><xref ref-type="bibr" rid="CR52">52</xref>,<xref ref-type="bibr" rid="CR53">53</xref></sup>. In our recently published work on understanding the &#8216;prophylactic period&#8217; for <italic toggle="yes">S. aureus</italic> growth and the evolution of susceptibility relevant to PJI, we used subcutaneous implantation and the contamination of material coupons. Using longitudinal susceptibility testing, bacterial gene expression, and immune profiling of the host (in addition to bacterial viability), we identified the acute period as the first 7 days after inoculation, after which the bacteria and the immune response equilibrated<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>. The bacterial evolution of antibiotic tolerance (for susceptible and inherently resistant bacteria) in vivo corresponded roughly to the first 6&#8201;h of in vitro culture. Thus, we identified 6&#8201;h of culture as a &#8216;nascent&#8217; biofilm and 24&#8201;h of culture as an &#8216;established&#8217; biofilm<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> and focused on the in-vitro study of the <italic toggle="yes">S. aureus</italic>-<italic toggle="yes">E. coli</italic> polymicrobial biofilm at 6 and 24 h as a period of potential intervention from a therapeutic and translational point of view.</p><p id="Par22">For the growth dynamics, the coexistence of <italic toggle="yes">E. coli</italic> with <italic toggle="yes">S. aureus</italic> (MSSA and MRSA) on implant surfaces led to a dramatic reduction in <italic toggle="yes">S. aureus</italic> biofilm viability, with significant reduction observed by 24&#8201;h and 48&#8201;h for MRSA and MSSA, respectively. At 48&#8201;h, persisting populations of MRSA were observed, indicating stronger competition from MRSA, potentially changing the dynamics of the polymicrobial biofilm beyond 48&#8201;h. <italic toggle="yes">E. coli</italic> biofilm viability remained unaffected throughout the study period. The data demonstrated that <italic toggle="yes">E. coli</italic> is the dominant viable species in the presence of <italic toggle="yes">S. aureus</italic> within a polymicrobial biofilm setting. This observation aligns with previous studies showing that <italic toggle="yes">E. coli</italic> can inhibit other biofilm-forming organisms through competitive and antagonistic mechanisms, including nutrient competition, secretion of biofilm-disrupting molecules, and quorum sensing regulation<sup><xref ref-type="bibr" rid="CR56">56</xref>&#8211;<xref ref-type="bibr" rid="CR58">58</xref></sup>. However, the conventional culture methods further limit our understanding of the exact viability status of <italic toggle="yes">S. aureus</italic> in the presence of <italic toggle="yes">E. coli</italic>.</p><p id="Par23">Colony characteristics revealed a wealth of information on the stress adaptation and metabolic activity of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> in a polymicrobial biofilm setting. SCVs, usually characterized by reduced metabolic activity and enhanced antibiotic tolerance<sup><xref ref-type="bibr" rid="CR59">59</xref>,<xref ref-type="bibr" rid="CR60">60</xref></sup>, were observed for <italic toggle="yes">S. aureus</italic> in the presence of <italic toggle="yes">E. coli</italic>. The mannitol fermentation capabilities of <italic toggle="yes">S. aureus</italic>, which is a determinant of its metabolic status<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>, were compromised by <italic toggle="yes">E. coli</italic>. The observations indicated a reduced mannitol metabolism by <italic toggle="yes">S. aureus</italic> within a polymicrobial environment that could facilitate their persistence under hostile conditions<sup><xref ref-type="bibr" rid="CR60">60</xref>,<xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR63">63</xref></sup>. For <italic toggle="yes">E. coli</italic>, the colonies on MacConkey agar demonstrated altered colony color and shape, indicating a bacterial response to <italic toggle="yes">S. aureus</italic>-induced stress, which triggered molecular regulation of metabolic pathways in <italic toggle="yes">E. coli</italic>. The SCV observation is novel and central to this study, which necessitates quantification and in-depth characterization utilizing a large number of samples to conclude the significance of the occurrence of <italic toggle="yes">S</italic><italic toggle="yes">. aureus</italic> persisters in the presence of <italic toggle="yes">E. coli</italic>.</p><p id="Par24">Fluorescent imaging revealed cohabitation of live <italic toggle="yes">S</italic><italic toggle="yes">. aureus</italic> cocci and <italic toggle="yes">E</italic><italic toggle="yes">.</italic> c<italic toggle="yes">oli</italic> rods on the implant material. Differential staining was challenging on unfixed samples, and alternative approaches (fluorescent bacterial strains) could aid in visualizing live polymicrobial biofilm. Under electron microscopy, the <italic toggle="yes">E. coli</italic> adhesion was notably less in the presence of <italic toggle="yes">S. aureus</italic> at 6&#8201;h, while the corresponding monomicrobial biofilm exhibited holes that are characteristic of intra- colony channels that facilitate nutrient and oxygen availability within the biofilm<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. A striking observation was that the presence of <italic toggle="yes">S. aureus</italic> improved <italic toggle="yes">E. coli</italic> attachment to the implant material starting at 24&#8201;h when compared to its monomicrobial biofilm. <italic toggle="yes">S. aureus</italic>, being adept at biofilm formation due to its putative adhesins and secreted matrix proteins, could provide a favorable environment for <italic toggle="yes">E. coli</italic> to adhere to surfaces and establish a biofilm<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. At 6&#8201;h, <italic toggle="yes">E. coli</italic> and MSSA adhered to implant materials similarly, forming discrete aggregates. In contrast, <italic toggle="yes">E. coli</italic> showed increased colonization in the presence of MRSA at 6&#8201;h. By 24&#8201;h, <italic toggle="yes">E. coli</italic> dominated the biofilm structure in dual-species implant-associated biofilms, with chain-like formations enveloping <italic toggle="yes">S. aureus</italic>. Contrary to the findings on mixed-species biofilms of <italic toggle="yes">E. coli</italic> with <italic toggle="yes">Salmonella</italic> and <italic toggle="yes">Enterococcus</italic>, our study suggest that in the presence of <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">E. coli</italic> forms stable biofilms, by developing a robust biofilm sheath and utilizing metabolic byproducts of <italic toggle="yes">S. aureus</italic><sup><xref ref-type="bibr" rid="CR65">65</xref>&#8211;<xref ref-type="bibr" rid="CR67">67</xref></sup>. The deflation of <italic toggle="yes">S. aureus</italic> cells, observed for MSSA in the presence of <italic toggle="yes">E. coli</italic>, indicates a loss of cellular integrity, possibly mediated by direct interactions or secreted antimicrobials such as colicins or other bacteriocins<sup><xref ref-type="bibr" rid="CR68">68</xref>,<xref ref-type="bibr" rid="CR69">69</xref></sup>. For MRSA, although viable cells were observed in the presence of <italic toggle="yes">E. coli</italic> at 24&#8201;h, the viability was not captured in agar plates, which suggests a non-culturable persister status<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>. <italic toggle="yes">E. coli</italic> biofilms also underwent morphological changes (shortened rods, furrowed cell morphology, reduced curli fibers, and biofilm sheath), highlighting adaptive responses to coexistence, which may include altered matrix production or surface adhesion strategies<sup><xref ref-type="bibr" rid="CR71">71</xref>,<xref ref-type="bibr" rid="CR72">72</xref></sup>.</p><p id="Par25">Gentamicin, being an integral part of local drug delivery approaches for PJI prophylaxis, was chosen for evaluating the MBEC of implant-associated polymicrobial cultures. The presence of <italic toggle="yes">E. coli</italic> significantly reduced the MBEC of gentamicin for MSSA, from 100&#8211;500&#8201;&#181;g/mL in mono-species biofilms to &lt;10&#8201;&#181;g/mL in dual-species biofilms. This enhanced susceptibility is likely due to the inhibition of <italic toggle="yes">S. aureus</italic> biofilm formation by <italic toggle="yes">E. coli</italic>, leading to reduced matrix-mediated protection<sup><xref ref-type="bibr" rid="CR73">73</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup>. Conversely, the MBEC for <italic toggle="yes">E. coli</italic> increased in dual-species biofilms, potentially due to enhanced biofilm maturation or changes in metabolic states<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. For MRSA, <italic toggle="yes">E. coli</italic> had a limited impact on gentamicin susceptibility at early timepoints but reduced the MBEC for established biofilms at 48&#8201;h. This selective effect underscores the complex interactions between the two species, which may involve differential gene expression, biofilm architecture, or metabolic compatibility.</p><p id="Par26">Gene expression analyses revealed significant changes in dual-species biofilms. In 6-ht biofilms, MSSA demonstrated upregulation of stress response (<italic toggle="yes">vraR</italic>, <italic toggle="yes">yjbH</italic>, <italic toggle="yes">sigB</italic>, <italic toggle="yes">agrA</italic>), adhesion (<italic toggle="yes">atl</italic>, <italic toggle="yes">spa</italic>, <italic toggle="yes">clfA</italic>), and biofilm-associated genes (<italic toggle="yes">icaA, icaD, agrA</italic>) in the presence of <italic toggle="yes">E. coli</italic> (Fig. <xref rid="Fig4" ref-type="fig">4a</xref>), suggesting an initial attempt to establish a biofilm despite competition from <italic toggle="yes">E. coli</italic><sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. However, MRSA showed substantial downregulation of these critical genes in nascent biofilms, indicating more potent competition from <italic toggle="yes">E. coli</italic> during the initial stages of biofilm formation. In 24-h biofilms, the <italic toggle="yes">sarA</italic> and <italic toggle="yes">spa</italic> expression was triggered in the presence of EC, while all other genes were deregulated, suggesting activation of critical stress adaptation by MSSA<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. For MRSA, the expression of pathogenicity-associated genes was triggered (<italic toggle="yes">yjbH</italic>, <italic toggle="yes">atl</italic>, <italic toggle="yes">clfA</italic>) together with the negative regulation of peptidoglycan biosynthesis (<italic toggle="yes">vraR</italic>) and protein A antigen (<italic toggle="yes">spa</italic>), indicating a potential switch to persister mode (SCVs) by MRSA, which could impact the outcome of PJI in a clinical setting<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>.</p><p id="Par27">Both MSSA and MRSA, in 6-h biofilms, triggered the upregulation of quorum sensing (<italic toggle="yes">sdiA, lacZ</italic>), biofilm formation (<italic toggle="yes">tomB</italic>), and stress-response (<italic toggle="yes">gyrA</italic>, <italic toggle="yes">rpoS</italic>) genes in <italic toggle="yes">E</italic><italic toggle="yes">. coli</italic> and colibactin-associated genes (<italic toggle="yes">clbA</italic>, <italic toggle="yes">clbB</italic>), consistent with enhanced biofilm formation, virulence, and stress adaptation<sup><xref ref-type="bibr" rid="CR78">78</xref>,<xref ref-type="bibr" rid="CR79">79</xref></sup>. Notably, the responses were significantly augmented in the presence of MRSA compared to MSSA. In 24-h biofilms, however, the <italic toggle="yes">E</italic><italic toggle="yes">.</italic>
<italic toggle="yes">coli</italic> responses were muted except for further activation of <italic toggle="yes">tomB</italic> in the presence of MSSA, suggesting further strengthening of the biofilm<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>. On the contrary, the presence of MRSA deregulated <italic toggle="yes">E</italic><italic toggle="yes">.</italic>
<italic toggle="yes">coli</italic> biofilm formation. The data demonstrated a strain-specific, biofilm maturity-dependent interaction dynamics by <italic toggle="yes">S</italic><italic toggle="yes">.</italic>
<italic toggle="yes">aureus</italic> within a dual-species biofilm with <italic toggle="yes">E</italic><italic toggle="yes">.</italic>
<italic toggle="yes">coli</italic> .</p><p id="Par28">In 6-h biofilms exposed to sub-inhibitory concentrations of gentamicin, the stress responses were activated in MSSA and subdued in MRSA compared to their respective controls. Notably, MSSA protein A (<italic toggle="yes">spa</italic>) was downregulated, likely in an antibiotic-mediated manner<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. The presence of <italic toggle="yes">E</italic><italic toggle="yes">.</italic>
<italic toggle="yes">coli</italic> and gentamicin highly impacted the physiological responses of MRSA compared to MSSA, indicating a synergistic action that could aid in MRSA eradication in its nascent biofilm stages. As biofilm maturity increased at 24-h, stress responses and biofilm-associated gene expression remained elevated in MSSA and MRSA in the presence of <italic toggle="yes">E</italic><italic toggle="yes">.</italic>
<italic toggle="yes">coli</italic> and gentamicin. Meanwhile, adhesion and virulence genes (<italic toggle="yes">clfA</italic>, <italic toggle="yes">sarA</italic>, and <italic toggle="yes">spa</italic>) were negatively regulated, suggesting the sustained synergistic action of <italic toggle="yes">E</italic><italic toggle="yes">.</italic>
<italic toggle="yes">coli</italic> and gentamicin against MSSA and MRSA. Taken together, <italic toggle="yes">E. coli</italic> is potentially the dominant species in an implant-associated polymicrobial biofilm with MSSA and MRSA and is capable of anti- <italic toggle="yes">S. aureus</italic> responses with and without the presence of broad-spectrum antibiotic, gentamicin.</p><p id="Par29">The observed suppression of <italic toggle="yes">S. aureus</italic> biofilm viability by <italic toggle="yes">E. coli</italic> suggests potential therapeutic strategies against <italic toggle="yes">S. aureus</italic>, leveraging competitive microbial interactions to manage biofilm-associated infections. For example, <italic toggle="yes">E. coli-derived</italic> metabolites could disrupt <italic toggle="yes">S. aureus</italic> biofilms on implants. Nevertheless, the persistence of <italic toggle="yes">E. coli</italic> biofilms on implants and their enhanced antibiotic resistance in dual-species settings pose challenges, as they may serve as reservoirs for chronic infection<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. Furthermore, the reduction in gentamicin MBEC for MSSA and the limited effect on MRSA highlight the need for tailored antibiotic regimens in polymicrobial infections. These findings also emphasize the importance of early intervention, as biofilm maturity significantly affects antibiotic susceptibility.</p><p id="Par30">Since <italic toggle="yes">S. aureus</italic> is the primary causative microorganism cultured from tissues extracted in PJIs, and <italic toggle="yes">E. coli</italic> is rarely encountered as a single causative microorganism, a limitation of the study is the inability to fully capture the in vivo environment of the polymicrobial interaction. Our previous work observed that the growth dynamics and MBEC evolution for gentamicin were different for <italic toggle="yes">S. aureus</italic> when implanted in the joint compared to subcutaneous implantation<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. A significant difference between these implant locations is the hypoxic environment in the joint, which can presumably favor <italic toggle="yes">S. aureus</italic> growth<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Future studies of polymicrobial infection will focus on the effect of hypoxia on interspecies interactions. Critical factors include suitable culture media to grow and maintain &#8220;realistic&#8221; implant-associated biofilm in vitro and dynamic culture conditions to capture acute and chronic infection periods without media depletion (for in vitro culture &gt;24&#8201;h). Synovial fluid or its substitutes in a dynamic setting could provide a clinically relevant environment<sup><xref ref-type="bibr" rid="CR83">83</xref>,<xref ref-type="bibr" rid="CR84">84</xref></sup>. Although standard laboratory techniques of bacterial culture use 10<sup>5</sup> CFU for inoculation, it has been shown that as few as 100 bacteria can cause an established infection in the presence of implant material<sup><xref ref-type="bibr" rid="CR85">85</xref></sup>. Further study of total inoculum and the ratio of contaminating organisms may also be appropriate. An inherent limitation of all standard microbiology techniques is the dependency of viability results on the compatibility of the specific microorganism with the plate culture, which is included after bacterial recovery from the original environment. Future studies should investigate the exact mechanisms by which <italic toggle="yes">E. coli</italic> inhibits <italic toggle="yes">S. aureus</italic> biofilm formation, including the role of secreted factors and nutrient competition. Additionally, exploring the impact of different antibiotics and implant materials on polymicrobial biofilms could inform the development of optimized treatment protocols and dosing requirements for antibiotic-eluting implant materials<sup><xref ref-type="bibr" rid="CR86">86</xref></sup>. Finally, in vivo studies are essential to validate these findings and assess their clinical relevance.</p><p id="Par31">Our long-term goal is to develop effective therapeutic strategies to prevent and treat PJI, and this study is the first in-depth investigation of implant-associated polymicrobial interactions to the best of our knowledge. Understanding and manipulating the behavior of <italic toggle="yes">S. aureus</italic> in mono- and polymicrobial cultures will help create clinically relevant information on bacterial characteristics and have the highest potential for decreasing infection rates.</p></sec><sec id="Sec8"><title>Methods</title><sec id="Sec9"><title>Bacterial strains and culture conditions</title><p id="Par32">Methicillin and gentamicin susceptible <italic toggle="yes">S. aureus</italic> control strain ATCC 12600 (MSSA) and gentamicin susceptible <italic toggle="yes">E. coli</italic> control strain ATCC 25922 (EC) were commercially obtained (MicroBiologics&#174;, MN, USA). Methicillin and gentamicin-resistant <italic toggle="yes">S. aureus</italic> clinical strain L1101 (Mu50; ATCC 700699 MRSA) was kindly provided by Dr Kerry Laplante (University of Rhode Island). The antibiotic susceptibility profiles of the bacterial strains are provided in Table <xref rid="MOESM1" ref-type="media">S1</xref> (Supplementary file). The lyophilized pellet or frozen glycerol stocks of bacteria were revived in Tryptic Soy Agar (TSA) plates statically incubated at 35&#8201;&#176;C for 16&#8211;18&#8201;h. The colonies were grown overnight in Tryptic Soy Broth (TSB) before all experiments. The turbidity was spectrophotometrically determined at 600&#8201;nm, and the bacterial load was enumerated using strain-specific standard growth curves (MSSA, <inline-formula id="IEq1"><alternatives><tex-math id="d33e1598">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y=\,7\times {10}^{8}\left(x\right)-3\times {10}^{7}$$\end{document}</tex-math><mml:math id="d33e1603"><mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:mn>7</mml:mn><mml:mo>&#215;</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>8</mml:mn></mml:mrow></mml:msup><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn><mml:mo>&#215;</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41522_2025_754_Article_IEq1.gif"/></alternatives></inline-formula>; MRSA, <inline-formula id="IEq2"><alternatives><tex-math id="d33e1630">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y$$\end{document}</tex-math><mml:math id="d33e1635"><mml:mi>y</mml:mi></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41522_2025_754_Article_IEq2.gif"/></alternatives></inline-formula>&#8201;=&#8201;<inline-formula id="IEq3"><alternatives><tex-math id="d33e1639">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$3\times \,{10}^{8}(x)-3\times {10}^{7}$$\end{document}</tex-math><mml:math id="d33e1644"><mml:mrow><mml:mn>3</mml:mn><mml:mo>&#215;</mml:mo><mml:mspace width="0.25em"/><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>8</mml:mn></mml:mrow></mml:msup><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn><mml:mo>&#215;</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>7</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41522_2025_754_Article_IEq3.gif"/></alternatives></inline-formula>; EC, <inline-formula id="IEq4"><alternatives><tex-math id="d33e1667">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y=\,8\times {10}^{8}(x)$$\end{document}</tex-math><mml:math id="d33e1672"><mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mspace width="0.25em"/><mml:mn>8</mml:mn><mml:mo>&#215;</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>8</mml:mn></mml:mrow></mml:msup><mml:mo>(</mml:mo><mml:mi>x</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41522_2025_754_Article_IEq4.gif"/></alternatives></inline-formula>).</p></sec><sec id="Sec10"><title>Biofilm growth dynamics</title><p id="Par33">To establish dual-species implant material-associated biofilms in vitro, 1&#8201;&#215;&#8201;10<sup>5</sup> CFU/mL of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> cultures (1:1) in 1mL TSB were seeded on 316&#8201;L stainless steel plates (SS plates, 10&#8201;&#215;&#8201;3&#8201;&#215;&#8201;1&#8201;mm<sup>3</sup>) within 24 well plates and statically incubated at 35&#8201;&#176;C for a period of 6, 24, and 48&#8201;h. At each time point, the spent media was aspirated, and the SS plates were washed 3&#215; for 2&#8201;min with sterile phosphate-buffered saline (PBS) to remove non-adherent bacteria. The plates were sonicated for 40&#8201;min (sonication time optimized for maximum bacteria recovery with minimum cell death) in 1&#8201;mL PBS (Fisher Scientific, USA), and the sonicate fluid was diluted and plated onto Mannitol salt agar and MacConkey agar to differentially count viable <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic>, respectively. The agar plates were statically incubated at 35&#8201;&#176;C for 16&#8211;18&#8201;h, and the viable adherent bacteria count was determined. Mono-species biofilms of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> grown on SS plates were controls for the experiment.</p></sec><sec id="Sec11"><title>Fluorescent biofilm viability assay</title><p id="Par34">The implant material-adhered dual-species biofilms from 6, 24, and 48&#8201;h were washed 3&#215; and sonicated in PBS for 40&#8201;min. The sonicate fluid was stained using LIVE BacLight Bacterial Gram Stain Kit (Invitrogen, USA) containing Syto9 and Hexidium iodide fluorescent stains. 5&#8201;&#181;L of sonicate fluid was mounted on glass slides, and differentially stained bacteria from 10 fields were counted using GFP and Texas Red filters in a Nikon Ti2 Eclipse microscope at 400X. The counts were analyzed using the Biofilm viability checker tool in Fiji image processing software, and the percentage viability for each species was quantified<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>.</p></sec><sec id="Sec12"><title>Biofilm visualization</title><p id="Par35">Dual-species biofilms grown on SS plates for 6, 24, and 48&#8201;h were washed 3x with PBS to remove non-adherent bacteria. The adherent biofilms on SS plates were stained by applying 200&#8201;&#181;L of diluted Syto9 dye on the surface to visualize live dual-species bacteria within the biofilm. The stained SS plates were mounted on coverslips and visualized at 600x using a Nikon Ti2 Eclipse microscope with a GFP filter. The adherent biofilms (dual and mono-species) were also visualized using scanning electron microscopy (SEM, n&#8201;=&#8201;3; six fields/sample)<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Briefly, the SS plate-adhered biofilms were washed 3x with PBS to remove non-adherent bacteria. The plates were fixed using 2.5% glutaraldehyde for a minimum of 48&#8201;h. The plates were subjected to 2% OsO4: 0.2% Ruthenium Red (1:1) staining for 1&#8201;h and washed thoroughly with deionized water (2&#215;,10&#8201;min each) before incubating with 1% tannic acid for 1&#8201;h. The SS plate-adhered biofilms were washed with deionized water (2&#215;, 10&#8201;min each) and air-dried completely before preparing the samples for SEM. The samples were visualized using Zeiss Gemini 560 FESEM at 1.5&#8211;3&#8201;kV and at 2&#8201;K, 5&#8201;K, and 10&#8201;K magnification. Mono-species biofilms on SS plates served as controls.</p></sec><sec id="Sec13"><title>Minimum biofilm eradication concentration (MBEC) measurement</title><p id="Par36">Biofilms grown on SS plates for 6, 24, and 48&#8201;h were washed 3&#215; with sterile PBS to remove non-adherent bacteria. The biofilms were exposed to a range of gentamicin concentrations (1&#8211;500&#8201;&#181;g/mL) prepared in 10% TSB supplemented PBS for 24&#8201;h at 35&#8201;&#176;C. The gentamicin-exposed biofilms were rinsed further with 3&#215; PBS for 2&#8201;min, and the viable adherent bacteria were determined using the differential plate count method described previously. The MBEC was the lowest concentration of gentamicin required to cause &gt; 3-log reduction in biofilm viability. Mono-species biofilms grown on SS plates for the indicated time points served as controls for this experiment.</p></sec><sec id="Sec14"><title>Bacterial RNA extraction</title><p id="Par37">Dual and mono-species biofilms were grown on 22&#8201;&#215;&#8201;22&#8201;mm SS plates for 6 and 24&#8201;h. At indicated time points, the plates were washed with PBS, and the material surface was swabbed thoroughly and resuspended in PBS. To determine the effect of gentamicin on the gene expression of SS-plate adhered dual-species biofilms, the biofilms grown for 6 and 24&#8201;h were exposed to sub-MBEC for gentamicin (Table <xref rid="MOESM1" ref-type="media">S2</xref>, Supplementary file) for a period of 24&#8201;h and processed as described above. The bacterial suspensions were centrifuged at 10,000&#8201;&#215;&#8201;<italic toggle="yes">g</italic> for 10&#8201;min, and the total bacterial RNA was extracted from the pellet using the RNeasy PowerBiofilm kit according to the manufacturer&#8217;s instructions (Qiagen, USA). The RNA was spectrophotometrically assessed using the NanoDrop&#8482; One (Thermo Fisher Scientific, USA).</p></sec><sec id="Sec15"><title>Quantitative PCR</title><p id="Par38">The bacterial RNA was converted to cDNA using the iScript&#8482; Reverse Transcription Supermix protocol (Bio-Rad, USA). The cDNA template was used to quantify the expression of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">E. coli</italic> genes using the iTaq&#8482; Universal SYBR Supermix (Bio-Rad, USA) and specific primers. The genes and their primers used in this study are provided in Table <xref rid="Tab1" ref-type="table">1</xref>. Bacterial <italic toggle="yes">16srRNA</italic> served as housekeeping gene to normalize the test gene expression. Mono-species bacterial gene expression served as a control for the experiment. The gene expression analysis was performed using the 2<sup>-&#8710;Cq</sup> method, and the expression fold change was determined for both dual-species and mono-species biofilms.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>List of primers</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="22" colspan="1"><italic toggle="yes">S. aureus</italic></td><td rowspan="2" colspan="1"><italic toggle="yes">vraR</italic></td><td colspan="1" rowspan="1">FP 5&#697;- AACTCTGCGCGCTTTTTCAT-3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- ATATCGCCGATGCAGTTCGT-3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">icaA</italic></td><td colspan="1" rowspan="1">FP 5&#697;-TTGTCGACGTTGGCTACTGG -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- GCGTTGCTTCCAAAGACCTC -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">icaD</italic></td><td colspan="1" rowspan="1">FP 5&#697;- CGCTATATCGTGTGTCTTTTGGA -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- TCGCGAAAATGCCCATAGTT -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">16srRNA</italic></td><td colspan="1" rowspan="1">FP 5&#697;- AGACCAGAAAGTCGCCTTCG -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;-TCAACCGTGGAGGGTCATTG -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">agrA</italic></td><td colspan="1" rowspan="1">FP 5&#697;- TGCCCTCGCAACTGATAATCC -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- TACCAACTGGGTCATGCTTACG -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">yjbH</italic></td><td colspan="1" rowspan="1">FP 5&#697;- CGGCACGTACACGACCTTG -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- TCCATTTAGCTCCGATTGCTTCA -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">sigB</italic></td><td colspan="1" rowspan="1">FP 5&#697;- AACCGATACGCTCACCTGTCT-3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- TGGGGCAACAAGATGACCA -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">atl</italic></td><td colspan="1" rowspan="1">FP 5&#697;- GTGTTGGTGTAGGCGTAGGT -3&#697;</td></tr><tr><td colspan="1" rowspan="1">FP 5&#697;- GTGTCTGGCTCTGGAAACCA -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">clfA</italic></td><td colspan="1" rowspan="1">FP 5&#697;- GCGGTTCAGATTCGGGTAGT -3&#697;</td></tr><tr><td colspan="1" rowspan="1">FP 5&#697;- CGCTCGCTGAGTCGGA -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">spa</italic></td><td colspan="1" rowspan="1">FP 5&#697;- AACGCTGCACCTAAGGCTAA -3&#697;</td></tr><tr><td colspan="1" rowspan="1">FP 5&#697;- CAGCAAACCATGCAGATGCT -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">sarA</italic></td><td colspan="1" rowspan="1">FP 5&#697;- CGTTGTTTGCTTCAGTGATTCG -3&#697;</td></tr><tr><td colspan="1" rowspan="1">FP 5&#697;- ACAACCACAAGTTGTTAAAGCAGT -3&#697;</td></tr><tr><td rowspan="16" colspan="1"><italic toggle="yes">E. coli</italic></td><td rowspan="2" colspan="1"><italic toggle="yes">tomB</italic></td><td colspan="1" rowspan="1">FP 5&#697;- CGATTACCTGACTTCCGCCA -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- CGGCGATCAACCTCCAGTT -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">lacZ</italic></td><td colspan="1" rowspan="1">FP 5&#697;- TGCTGCTGGTGTTTTGCTTC -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- GGCGGTGATTTTGGCGATAC -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">clbA</italic></td><td colspan="1" rowspan="1">FP 5&#697;- TACGTGCAAATATGGCAAAC -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- CTAATAGCAACGGCTACTGT -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">clbB</italic></td><td colspan="1" rowspan="1">FP 5&#697;- TCAAGGTAGCCAATATCACG -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- ATCCTCATCGTCAAACAACA -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">sdiA</italic></td><td colspan="1" rowspan="1">FP 5&#697;- GCTGATGTTTTCCCTTCCGC -3&#697;</td></tr><tr><td colspan="1" rowspan="1">FP 5&#697;- TTACTGGTGCGCGAAAGTCT -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">gyrA</italic></td><td colspan="1" rowspan="1">FP 5&#697;- GCTTAACAACCTCTACTCCC -3&#697;</td></tr><tr><td colspan="1" rowspan="1">FP 5&#697;- CTTCAAGGATATGAGCACGA -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">rpoS</italic></td><td colspan="1" rowspan="1">FP 5&#697;- AATCGCCCGTTCAATCGTCT -3&#697;</td></tr><tr><td colspan="1" rowspan="1">FP 5&#697;- GGTAAAAATTGCCCGCCGTT -3&#697;</td></tr><tr><td rowspan="2" colspan="1"><italic toggle="yes">16srRNA</italic></td><td colspan="1" rowspan="1">FP 5&#697;- CTTGCTGCTTTGCTGACGAG -3&#697;</td></tr><tr><td colspan="1" rowspan="1">RP 5&#697;- GGTCCCCCTCTTTGGTCTTG -3&#697;</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec16"><title>Statistical analysis</title><p id="Par39">Welch&#8217;s <italic toggle="yes">t</italic>&#8201;test was performed for the growth dynamics, MBEC data, and gene expression datasets to compare dual-species vs. mono-species biofilms and analyze MRSA vs MSSA groups. <italic toggle="yes">P</italic>&#8201;value&#8201;&lt;&#8201;0.05 was considered statistically significant. The <italic toggle="yes">p</italic>&#8201;value corresponding to each data point is included in the figures and the supplementary file (Tables <xref rid="MOESM1" ref-type="media">S3</xref>, <xref rid="MOESM1" ref-type="media">S4</xref>).</p></sec></sec><sec id="Sec17" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41522_2025_754_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary information</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41522-025-00754-2.</p></sec><ack><title>Acknowledgements</title><p>This study was funded by National Institutes of Health Grant R01AR077023. The authors thank Dr. Kerry Laplante at the University of Rhode Island for providing the clinical MRSA strain. This work was performed in part at the Harvard University Center for Nanoscale Systems (CNS); a member of the National Nanotechnology Coordinated Infrastructure Network (NNCI), which is supported by the National Science Foundation under NSF award no. 651 ECCS-2025158.The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>A.S. and E.O. conceptualized the study and wrote the paper. A.S., F.B.M., S.U.D., performed the bacterial growth characterization and antibiotic susceptibility studies. A.S., F.B.M., S.U.D., and N.I. performed the imaging. A.S., F.B.M., and D.M., performed the qPCR analyses. E.O. acquired the funding and E.O. and O.K.M. supervised the study. All authors read and approved the final manuscript.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are provided within the manuscript and supplementary file.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par40">Authors A.S., F.B.M., S.U.D., N.I. and D.M. declare no financial and non-financial competing interests. O.K.M. receives royalties from Corin, Mako, Iconacy, Renovis, Arthrex, ConforMIS, Meril Healthcare, Exactech, Cambridge Polymer Group; holds stake/equity in Cambridge Polymer Group, Orthopedic Technology Group, Alchimist and declares no non-financial competing interests. E.O. receives royalties from Corin, Iconacy, Renovis, Arthrex, ConforMIS, Meril Healthcare, and Exactech and is a paid consultant for WL Gore &amp; Assoc. EO declares the following non-financial competing interests; serves as Editor for The Journal of Biomedical Materials Research and as Officer/ in Committee of Society For Biomaterials (SFB) and International Society for Technology in Arthroplasty (ISTA).</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Two-stage exchange Arthroplasty for knee Periprosthetic joint infection exhibit high infection recurrence rate in patients with chronic viral hepatitis</article-title><source>BMC Musculoskelet. Disord.</source><year>2021</year><volume>22</volume><fpage>538</fpage><pub-id pub-id-type="doi">10.1186/s12891-021-04416-0</pub-id><pub-id pub-id-type="pmid">34118906</pub-id><pub-id pub-id-type="pmcid">PMC8199816</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Chen, J. et al. Two-stage exchange Arthroplasty for knee Periprosthetic joint infection exhibit high infection recurrence rate in patients with chronic viral hepatitis. <italic toggle="yes">BMC Musculoskelet. Disord.</italic><bold>22</bold>, 538 (2021).<pub-id pub-id-type="pmid">34118906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12891-021-04416-0</pub-id><pub-id pub-id-type="pmcid">PMC8199816</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Ayoade, F., Li, D., Mabrouk, A. &amp; Todd, J. R. <italic toggle="yes">Periprosthetic Joint Infection</italic>. (2025).<pub-id pub-id-type="pmid">28846340</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le Vavasseur</surname><given-names>B</given-names></name><name name-style="western"><surname>Zeller</surname><given-names>V</given-names></name></person-group><article-title>Antibiotic therapy for prosthetic joint infections: An overview</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><fpage>486</fpage><pub-id pub-id-type="doi">10.3390/antibiotics11040486</pub-id><pub-id pub-id-type="pmid">35453237</pub-id><pub-id pub-id-type="pmcid">PMC9025623</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Le Vavasseur, B. &amp; Zeller, V. Antibiotic therapy for prosthetic joint infections: An overview. <italic toggle="yes">Antibiotics</italic><bold>11</bold>, 486 (2022).<pub-id pub-id-type="pmid">35453237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics11040486</pub-id><pub-id pub-id-type="pmcid">PMC9025623</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rottier</surname><given-names>W</given-names></name><name name-style="western"><surname>Seidelman</surname><given-names>J</given-names></name><name name-style="western"><surname>Wouthuyzen-Bakker</surname><given-names>M</given-names></name></person-group><article-title>Antimicrobial treatment of patients with a periprosthetic joint infection: basic principles</article-title><source>Arthroplasty</source><year>2023</year><volume>5</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1186/s42836-023-00169-4</pub-id><pub-id pub-id-type="pmid">36864531</pub-id><pub-id pub-id-type="pmcid">PMC9979546</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Rottier, W., Seidelman, J. &amp; Wouthuyzen-Bakker, M. Antimicrobial treatment of patients with a periprosthetic joint infection: basic principles. <italic toggle="yes">Arthroplasty</italic><bold>5</bold>, 10 (2023).<pub-id pub-id-type="pmid">36864531</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s42836-023-00169-4</pub-id><pub-id pub-id-type="pmcid">PMC9979546</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koh</surname><given-names>CK</given-names></name><etal/></person-group><article-title>Periprosthetic joint infection is the main cause of failure for modern knee arthroplasty: An analysis of 11,134 knees</article-title><source>Clin. Orthop. Relat. Res.</source><year>2017</year><volume>475</volume><fpage>2194</fpage><lpage>2201</lpage><pub-id pub-id-type="doi">10.1007/s11999-017-5396-4</pub-id><pub-id pub-id-type="pmid">28573549</pub-id><pub-id pub-id-type="pmcid">PMC5539036</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Koh, C. K. et al. Periprosthetic joint infection is the main cause of failure for modern knee arthroplasty: An analysis of 11,134 knees. <italic toggle="yes">Clin. Orthop. Relat. Res.</italic><bold>475</bold>, 2194&#8211;2201 (2017).<pub-id pub-id-type="pmid">28573549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11999-017-5396-4</pub-id><pub-id pub-id-type="pmcid">PMC5539036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marculescu</surname><given-names>CE</given-names></name><name name-style="western"><surname>Cantey</surname><given-names>RJ</given-names></name></person-group><article-title>Polymicrobial prosthetic joint infections: Risk factors and outcome</article-title><source>Clin. Orthop. Relat. Res</source><year>2008</year><volume>466</volume><fpage>1397</fpage><lpage>1404</lpage><pub-id pub-id-type="doi">10.1007/s11999-008-0230-7</pub-id><pub-id pub-id-type="pmid">18421538</pub-id><pub-id pub-id-type="pmcid">PMC2384015</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Marculescu, C. E. &amp; Cantey, R. J. Polymicrobial prosthetic joint infections: Risk factors and outcome. <italic toggle="yes">Clin. Orthop. Relat. Res</italic><bold>466</bold>, 1397&#8211;1404 (2008).<pub-id pub-id-type="pmid">18421538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11999-008-0230-7</pub-id><pub-id pub-id-type="pmcid">PMC2384015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flurin</surname><given-names>L</given-names></name><name name-style="western"><surname>Greenwood-Quaintance</surname><given-names>KE</given-names></name><name name-style="western"><surname>Patel</surname><given-names>R</given-names></name></person-group><article-title>Microbiology of polymicrobial prosthetic joint infection</article-title><source>Diagn. Microbiol Infect. Dis.</source><year>2019</year><volume>94</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2019.01.006</pub-id><pub-id pub-id-type="pmid">30738691</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Flurin, L., Greenwood-Quaintance, K. E. &amp; Patel, R. Microbiology of polymicrobial prosthetic joint infection. <italic toggle="yes">Diagn. Microbiol Infect. Dis.</italic><bold>94</bold>, 255&#8211;259 (2019).<pub-id pub-id-type="pmid">30738691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.diagmicrobio.2019.01.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>K</given-names></name></person-group><article-title>Enterococci facilitate polymicrobial infections</article-title><source>Trends Microbiol</source><year>2024</year><volume>32</volume><fpage>162</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2023.07.010</pub-id><pub-id pub-id-type="pmid">37550091</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Xu, W., Fang, Y. &amp; Zhu, K. Enterococci facilitate polymicrobial infections. <italic toggle="yes">Trends Microbiol</italic><bold>32</bold>, 162&#8211;177 (2024).<pub-id pub-id-type="pmid">37550091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tim.2023.07.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bozhkova</surname><given-names>S</given-names></name><etal/></person-group><article-title>Failure of the first step of two-stage revision due to polymicrobial prosthetic joint infection of the hip</article-title><source>J. Orthop. Traumatol.</source><year>2016</year><volume>17</volume><fpage>369</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1007/s10195-016-0417-8</pub-id><pub-id pub-id-type="pmid">27387172</pub-id><pub-id pub-id-type="pmcid">PMC5071240</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Bozhkova, S. et al. Failure of the first step of two-stage revision due to polymicrobial prosthetic joint infection of the hip. <italic toggle="yes">J. Orthop. Traumatol.</italic><bold>17</bold>, 369&#8211;376 (2016).<pub-id pub-id-type="pmid">27387172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10195-016-0417-8</pub-id><pub-id pub-id-type="pmcid">PMC5071240</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fr&#246;schen</surname><given-names>FS</given-names></name><name name-style="western"><surname>Randau</surname><given-names>TM</given-names></name><name name-style="western"><surname>Franz</surname><given-names>A</given-names></name><name name-style="western"><surname>Molitor</surname><given-names>E</given-names></name><name name-style="western"><surname>Hischebeth</surname><given-names>GTR</given-names></name></person-group><article-title>Microbiological profiles of patients with periprosthetic joint infection of the hip or knee</article-title><source>Diagnostics</source><year>2022</year><volume>12</volume><fpage>1654</fpage><pub-id pub-id-type="doi">10.3390/diagnostics12071654</pub-id><pub-id pub-id-type="pmid">35885558</pub-id><pub-id pub-id-type="pmcid">PMC9316097</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Fr&#246;schen, F. S., Randau, T. M., Franz, A., Molitor, E. &amp; Hischebeth, G. T. R. Microbiological profiles of patients with periprosthetic joint infection of the hip or knee. <italic toggle="yes">Diagnostics</italic><bold>12</bold>, 1654 (2022).<pub-id pub-id-type="pmid">35885558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/diagnostics12071654</pub-id><pub-id pub-id-type="pmcid">PMC9316097</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez</surname><given-names>PM</given-names></name><name name-style="western"><surname>Veliky</surname><given-names>C</given-names></name><name name-style="western"><surname>McKeon</surname><given-names>J</given-names></name><name name-style="western"><surname>Chonko</surname><given-names>D</given-names></name></person-group><article-title>Polymicrobial prosthetic joint infection: Unusual presentation requiring a multidisciplinary and patient centered approach to treatment</article-title><source>J. Orthop. Rep.</source><year>2025</year><volume>4</volume><fpage>100562</fpage><pub-id pub-id-type="doi">10.1016/j.jorep.2025.100562</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Alvarez, P. M., Veliky, C., McKeon, J. &amp; Chonko, D. Polymicrobial prosthetic joint infection: Unusual presentation requiring a multidisciplinary and patient centered approach to treatment. <italic toggle="yes">J. Orthop. Rep.</italic><bold>4</bold>, 100562 (2025).</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tai</surname><given-names>DBG</given-names></name><name name-style="western"><surname>Patel</surname><given-names>R</given-names></name><name name-style="western"><surname>Abdel</surname><given-names>MP</given-names></name><name name-style="western"><surname>Berbari</surname><given-names>EF</given-names></name><name name-style="western"><surname>Tande</surname><given-names>AJ</given-names></name></person-group><article-title>Microbiology of hip and knee periprosthetic joint infections: A database study</article-title><source>Clin. Microbiol Infect.</source><year>2022</year><volume>28</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2021.06.006</pub-id><pub-id pub-id-type="pmid">34129907</pub-id><pub-id pub-id-type="pmcid">PMC8665939</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Tai, D. B. G., Patel, R., Abdel, M. P., Berbari, E. F. &amp; Tande, A. J. Microbiology of hip and knee periprosthetic joint infections: A database study. <italic toggle="yes">Clin. Microbiol Infect.</italic><bold>28</bold>, 255&#8211;259 (2022).<pub-id pub-id-type="pmid">34129907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmi.2021.06.006</pub-id><pub-id pub-id-type="pmcid">PMC8665939</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H-J</given-names></name><etal/></person-group><article-title>Prevalence of multidrug-resistant bacteria associated with polymicrobial infections</article-title><source>J. Infect. Public Health</source><year>2021</year><volume>14</volume><fpage>1864</fpage><lpage>1869</lpage><pub-id pub-id-type="doi">10.1016/j.jiph.2021.11.005</pub-id><pub-id pub-id-type="pmid">34801434</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Kim, H.-J. et al. Prevalence of multidrug-resistant bacteria associated with polymicrobial infections. <italic toggle="yes">J. Infect. Public Health</italic><bold>14</bold>, 1864&#8211;1869 (2021).<pub-id pub-id-type="pmid">34801434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jiph.2021.11.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michaelis</surname><given-names>C</given-names></name><name name-style="western"><surname>Grohmann</surname><given-names>E</given-names></name></person-group><article-title>Horizontal gene transfer of antibiotic resistance genes in biofilms</article-title><source>Antibiotics</source><year>2023</year><volume>12</volume><fpage>328</fpage><pub-id pub-id-type="doi">10.3390/antibiotics12020328</pub-id><pub-id pub-id-type="pmid">36830238</pub-id><pub-id pub-id-type="pmcid">PMC9952180</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Michaelis, C. &amp; Grohmann, E. Horizontal gene transfer of antibiotic resistance genes in biofilms. <italic toggle="yes">Antibiotics</italic><bold>12</bold>, 328 (2023).<pub-id pub-id-type="pmid">36830238</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics12020328</pub-id><pub-id pub-id-type="pmcid">PMC9952180</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wouthuyzen-Bakker</surname><given-names>M</given-names></name></person-group><article-title>Cultures in periprosthetic joint infections, the imperfect gold standard?</article-title><source>EFORT Open Rev.</source><year>2023</year><volume>8</volume><fpage>175</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1530/EOR-22-0115</pub-id><pub-id pub-id-type="pmid">37097061</pub-id><pub-id pub-id-type="pmcid">PMC10155123</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Wouthuyzen-Bakker, M. Cultures in periprosthetic joint infections, the imperfect gold standard?. <italic toggle="yes">EFORT Open Rev.</italic><bold>8</bold>, 175&#8211;179 (2023).<pub-id pub-id-type="pmid">37097061</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1530/EOR-22-0115</pub-id><pub-id pub-id-type="pmcid">PMC10155123</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>TL</given-names></name><etal/></person-group><article-title>Defining treatment success after 2-stage exchange arthroplasty for periprosthetic joint infection</article-title><source>J. Arthroplast.</source><year>2018</year><volume>33</volume><fpage>3541</fpage><lpage>3546</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2018.06.015</pub-id><pub-id pub-id-type="pmid">30100137</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Tan, T. L. et al. Defining treatment success after 2-stage exchange arthroplasty for periprosthetic joint infection. <italic toggle="yes">J. Arthroplast.</italic><bold>33</bold>, 3541&#8211;3546 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2018.06.015</pub-id><pub-id pub-id-type="pmid">30100137</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trampuz</surname><given-names>A</given-names></name><etal/></person-group><article-title>Advances in the laboratory diagnosis of prosthetic joint infection</article-title><source>Rev. Med. Microbiol.</source><year>2003</year><volume>14</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1097/00013542-200301000-00001</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Trampuz, A. et al. Advances in the laboratory diagnosis of prosthetic joint infection. <italic toggle="yes">Rev. Med. Microbiol.</italic><bold>14</bold>, 1&#8211;14 (2003).</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mei</surname><given-names>J</given-names></name><etal/></person-group><article-title>Diagnostic role of mNGS in polymicrobial periprosthetic joint infection</article-title><source>J. Clin. Med.</source><year>2023</year><volume>12</volume><fpage>1838</fpage><pub-id pub-id-type="doi">10.3390/jcm12051838</pub-id><pub-id pub-id-type="pmid">36902625</pub-id><pub-id pub-id-type="pmcid">PMC10003677</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Mei, J. et al. Diagnostic role of mNGS in polymicrobial periprosthetic joint infection. <italic toggle="yes">J. Clin. Med.</italic><bold>12</bold>, 1838 (2023).<pub-id pub-id-type="pmid">36902625</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm12051838</pub-id><pub-id pub-id-type="pmcid">PMC10003677</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benito</surname><given-names>N</given-names></name><etal/></person-group><article-title>The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms</article-title><source>J. Clin. Med.</source><year>2019</year><volume>8</volume><fpage>673</fpage><pub-id pub-id-type="doi">10.3390/jcm8050673</pub-id><pub-id pub-id-type="pmid">31086080</pub-id><pub-id pub-id-type="pmcid">PMC6572185</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Benito, N. et al. The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms. <italic toggle="yes">J. Clin. Med.</italic><bold>8</bold>, 673 (2019).<pub-id pub-id-type="pmid">31086080</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm8050673</pub-id><pub-id pub-id-type="pmcid">PMC6572185</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><etal/></person-group><article-title>Risk of recurrent staphylococcus aureus prosthetic joint infection in rheumatoid arthritis patients&#8212;a nationwide cohort study</article-title><source>Open Forum Infect Dis.</source><year>2019</year><volume>6</volume><fpage>ofz451</fpage><pub-id pub-id-type="doi">10.1093/ofid/ofz451</pub-id><pub-id pub-id-type="pmid">31737738</pub-id><pub-id pub-id-type="pmcid">PMC6847211</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Singh, N. et al. Risk of recurrent staphylococcus aureus prosthetic joint infection in rheumatoid arthritis patients&#8212;a nationwide cohort study. <italic toggle="yes">Open Forum Infect Dis.</italic><bold>6</bold>, ofz451 (2019).<pub-id pub-id-type="pmid">31737738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ofid/ofz451</pub-id><pub-id pub-id-type="pmcid">PMC6847211</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hajdamowicz</surname><given-names>NH</given-names></name><name name-style="western"><surname>Hull</surname><given-names>RC</given-names></name><name name-style="western"><surname>Foster</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Condliffe</surname><given-names>AM</given-names></name></person-group><article-title>The impact of hypoxia on the host-pathogen interaction between neutrophils and staphylococcus aureus</article-title><source>Int J. Mol. Sci.</source><year>2019</year><volume>20</volume><fpage>5561</fpage><pub-id pub-id-type="doi">10.3390/ijms20225561</pub-id><pub-id pub-id-type="pmid">31703398</pub-id><pub-id pub-id-type="pmcid">PMC6888323</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Hajdamowicz, N. H., Hull, R. C., Foster, S. J. &amp; Condliffe, A. M. The impact of hypoxia on the host-pathogen interaction between neutrophils and staphylococcus aureus. <italic toggle="yes">Int J. Mol. Sci.</italic><bold>20</bold>, 5561 (2019).<pub-id pub-id-type="pmid">31703398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms20225561</pub-id><pub-id pub-id-type="pmcid">PMC6888323</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>CT</given-names></name><etal/></person-group><article-title>Synovial tissue hypoxia and inflammation in vivo</article-title><source>Ann. Rheum. Dis.</source><year>2010</year><volume>69</volume><fpage>1389</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.1136/ard.2009.119776</pub-id><pub-id pub-id-type="pmid">20439288</pub-id><pub-id pub-id-type="pmcid">PMC2946116</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ng, C. T. et al. Synovial tissue hypoxia and inflammation in vivo. <italic toggle="yes">Ann. Rheum. Dis.</italic><bold>69</bold>, 1389&#8211;1395 (2010).<pub-id pub-id-type="pmid">20439288</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/ard.2009.119776</pub-id><pub-id pub-id-type="pmcid">PMC2946116</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kragh</surname><given-names>KN</given-names></name><name name-style="western"><surname>Tolker-Nielsen</surname><given-names>T</given-names></name><name name-style="western"><surname>Lichtenberg</surname><given-names>M</given-names></name></person-group><article-title>The non-attached biofilm aggregate</article-title><source>Commun. Biol.</source><year>2023</year><volume>6</volume><fpage>898</fpage><pub-id pub-id-type="doi">10.1038/s42003-023-05281-4</pub-id><pub-id pub-id-type="pmid">37658117</pub-id><pub-id pub-id-type="pmcid">PMC10474055</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kragh, K. N., Tolker-Nielsen, T. &amp; Lichtenberg, M. The non-attached biofilm aggregate. <italic toggle="yes">Commun. Biol.</italic><bold>6</bold>, 898 (2023).<pub-id pub-id-type="pmid">37658117</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42003-023-05281-4</pub-id><pub-id pub-id-type="pmcid">PMC10474055</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staats</surname><given-names>A</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>AC</given-names></name><name name-style="western"><surname>Stoodley</surname><given-names>P</given-names></name></person-group><article-title>Biofilm formation in periprosthetic joint infections</article-title><source>Ann. Jt</source><year>2021</year><volume>6</volume><fpage>43</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.21037/aoj-20-85</pub-id><pub-id pub-id-type="pmid">34859164</pub-id><pub-id pub-id-type="pmcid">PMC8635410</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Staats, A., Li, D., Sullivan, A. C. &amp; Stoodley, P. Biofilm formation in periprosthetic joint infections. <italic toggle="yes">Ann. Jt</italic><bold>6</bold>, 43&#8211;43 (2021).<pub-id pub-id-type="pmid">34859164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/aoj-20-85</pub-id><pub-id pub-id-type="pmcid">PMC8635410</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knott</surname><given-names>S</given-names></name><etal/></person-group><article-title>Staphylococcus aureus floating biofilm formation and phenotype in synovial fluid depends on albumin, fibrinogen, and hyaluronic acid</article-title><source>Front Microbiol</source><year>2021</year><volume>12</volume><fpage>655873</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.655873</pub-id><pub-id pub-id-type="pmid">33995317</pub-id><pub-id pub-id-type="pmcid">PMC8117011</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Knott, S. et al. Staphylococcus aureus floating biofilm formation and phenotype in synovial fluid depends on albumin, fibrinogen, and hyaluronic acid. <italic toggle="yes">Front Microbiol</italic><bold>12</bold>, 655873 (2021).<pub-id pub-id-type="pmid">33995317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2021.655873</pub-id><pub-id pub-id-type="pmcid">PMC8117011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howden</surname><given-names>BP</given-names></name><etal/></person-group><article-title>Staphylococcus aureus host interactions and adaptation</article-title><source>Nat. Rev. Microbiol</source><year>2023</year><volume>21</volume><fpage>380</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/s41579-023-00852-y</pub-id><pub-id pub-id-type="pmid">36707725</pub-id><pub-id pub-id-type="pmcid">PMC9882747</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Howden, B. P. et al. Staphylococcus aureus host interactions and adaptation. <italic toggle="yes">Nat. Rev. Microbiol</italic><bold>21</bold>, 380&#8211;395 (2023).<pub-id pub-id-type="pmid">36707725</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41579-023-00852-y</pub-id><pub-id pub-id-type="pmcid">PMC9882747</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Dong</surname><given-names>W</given-names></name><name name-style="western"><surname>Sun</surname><given-names>N</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>W</given-names></name></person-group><article-title>A Review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism</article-title><source>Antibiotics</source><year>2022</year><volume>12</volume><fpage>12</fpage><pub-id pub-id-type="doi">10.3390/antibiotics12010012</pub-id><pub-id pub-id-type="pmid">36671212</pub-id><pub-id pub-id-type="pmcid">PMC9854888</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Peng, Q., Tang, X., Dong, W., Sun, N. &amp; Yuan, W. A Review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism. <italic toggle="yes">Antibiotics</italic><bold>12</bold>, 12 (2022).<pub-id pub-id-type="pmid">36671212</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics12010012</pub-id><pub-id pub-id-type="pmcid">PMC9854888</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tam</surname><given-names>K</given-names></name><etal/></person-group><article-title>Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia</article-title><source>J. Exp. Med.</source><year>2020</year><volume>217</volume><fpage>e20190541</fpage><pub-id pub-id-type="doi">10.1084/jem.20190541</pub-id><pub-id pub-id-type="pmid">32602902</pub-id><pub-id pub-id-type="pmcid">PMC7478724</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Tam, K. et al. Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia. <italic toggle="yes">J. Exp. Med.</italic><bold>217</bold>, e20190541 (2020).<pub-id pub-id-type="pmid">32602902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20190541</pub-id><pub-id pub-id-type="pmcid">PMC7478724</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">de Jong, N. W. M., van Kessel, K. P. M. &amp; van Strijp, J. A. G. Immune Evasion by Staphylococcus aureus. <italic toggle="yes">Microbiol Spectr</italic><bold>7</bold>, (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/microbiolspec.gpp3-0061-2019</pub-id><pub-id pub-id-type="pmcid">PMC11590434</pub-id><pub-id pub-id-type="pmid">30927347</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davidson</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Spratt</surname><given-names>D</given-names></name><name name-style="western"><surname>Liddle</surname><given-names>AD</given-names></name></person-group><article-title>Implant materials and prosthetic joint infection: the battle with the biofilm</article-title><source>EFORT Open Rev.</source><year>2019</year><volume>4</volume><fpage>633</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1302/2058-5241.4.180095</pub-id><pub-id pub-id-type="pmid">31754470</pub-id><pub-id pub-id-type="pmcid">PMC6851527</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Davidson, D. J., Spratt, D. &amp; Liddle, A. D. Implant materials and prosthetic joint infection: the battle with the biofilm. <italic toggle="yes">EFORT Open Rev.</italic><bold>4</bold>, 633&#8211;639 (2019).<pub-id pub-id-type="pmid">31754470</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/2058-5241.4.180095</pub-id><pub-id pub-id-type="pmcid">PMC6851527</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masters</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Evolving concepts in bone infection: redefining &#8220;biofilm&#8221;, &#8220;acute vs. chronic osteomyelitis&#8221;, &#8220;the immune proteome&#8221; and &#8220;local antibiotic therapy&#8221;</article-title><source>Bone Res.</source><year>2019</year><volume>7</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1038/s41413-019-0061-z</pub-id><pub-id pub-id-type="pmid">31646012</pub-id><pub-id pub-id-type="pmcid">PMC6804538</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Masters, E. A. et al. Evolving concepts in bone infection: redefining &#8220;biofilm&#8221;, &#8220;acute vs. chronic osteomyelitis&#8221;, &#8220;the immune proteome&#8221; and &#8220;local antibiotic therapy&#8221;. <italic toggle="yes">Bone Res.</italic><bold>7</bold>, 20 (2019).<pub-id pub-id-type="pmid">31646012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41413-019-0061-z</pub-id><pub-id pub-id-type="pmcid">PMC6804538</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hays</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Increased incidence of methicillin-resistant staphylococcus aureus in knee and hip prosthetic joint infection</article-title><source>J. Arthroplast.</source><year>2023</year><volume>38</volume><fpage>S326</fpage><lpage>S330</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2023.02.025</pub-id><pub-id pub-id-type="pmid">36813212</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Hays, M. R. et al. Increased incidence of methicillin-resistant staphylococcus aureus in knee and hip prosthetic joint infection. <italic toggle="yes">J. Arthroplast.</italic><bold>38</bold>, S326&#8211;S330 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2023.02.025</pub-id><pub-id pub-id-type="pmid">36813212</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>MT</given-names></name><name name-style="western"><surname>Sridharan</surname><given-names>SS</given-names></name><name name-style="western"><surname>Davison</surname><given-names>EM</given-names></name><name name-style="western"><surname>Ng</surname><given-names>R</given-names></name><name name-style="western"><surname>Desy</surname><given-names>NM</given-names></name></person-group><article-title>Can topical vancomycin prevent periprosthetic joint infection in hip and knee arthroplasty? a systematic review</article-title><source>Clin. Orthop. Relat. Res.</source><year>2021</year><volume>479</volume><fpage>1655</fpage><lpage>1664</lpage><pub-id pub-id-type="doi">10.1097/CORR.0000000000001777</pub-id><pub-id pub-id-type="pmid">33929342</pub-id><pub-id pub-id-type="pmcid">PMC8277283</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Wong, M. T., Sridharan, S. S., Davison, E. M., Ng, R. &amp; Desy, N. M. Can topical vancomycin prevent periprosthetic joint infection in hip and knee arthroplasty? a systematic review. <italic toggle="yes">Clin. Orthop. Relat. Res.</italic><bold>479</bold>, 1655&#8211;1664 (2021).<pub-id pub-id-type="pmid">33929342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CORR.0000000000001777</pub-id><pub-id pub-id-type="pmcid">PMC8277283</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sekar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Investigating the translational value of periprosthetic joint infection models to determine the risk and severity of staphylococcal biofilms</article-title><source>ACS Infect. Dis.</source><year>2024</year><volume>10</volume><fpage>4156</fpage><lpage>4166</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.4c00409</pub-id><pub-id pub-id-type="pmid">39630924</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Sekar, A. et al. Investigating the translational value of periprosthetic joint infection models to determine the risk and severity of staphylococcal biofilms. <italic toggle="yes">ACS Infect. Dis.</italic><bold>10</bold>, 4156&#8211;4166 (2024).<pub-id pub-id-type="pmid">39630924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsinfecdis.4c00409</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veerman</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Assessment of antimicrobial mismatches in empirical treatment in early PJI after aseptic revision arthroplasty</article-title><source>JAC Antimicrob. Resist.</source><year>2022</year><volume>4</volume><fpage>dlac124</fpage><pub-id pub-id-type="doi">10.1093/jacamr/dlac124</pub-id><pub-id pub-id-type="pmid">36506891</pub-id><pub-id pub-id-type="pmcid">PMC9728518</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Veerman, C. M. et al. Assessment of antimicrobial mismatches in empirical treatment in early PJI after aseptic revision arthroplasty. <italic toggle="yes">JAC Antimicrob. Resist.</italic><bold>4</bold>, dlac124 (2022).<pub-id pub-id-type="pmid">36506891</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jacamr/dlac124</pub-id><pub-id pub-id-type="pmcid">PMC9728518</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>TL</given-names></name><name name-style="western"><surname>Kheir</surname><given-names>MM</given-names></name><name name-style="western"><surname>Tan</surname><given-names>DD</given-names></name><name name-style="western"><surname>Parvizi</surname><given-names>J</given-names></name></person-group><article-title>Polymicrobial periprosthetic joint infections: Outcome of treatment and identification of risk factors</article-title><source>J. Bone Jt. Surg.</source><year>2016</year><volume>98</volume><fpage>2082</fpage><lpage>2088</lpage><pub-id pub-id-type="doi">10.2106/JBJS.15.01450</pub-id><pub-id pub-id-type="pmid">28002371</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Tan, T. L., Kheir, M. M., Tan, D. D. &amp; Parvizi, J. Polymicrobial periprosthetic joint infections: Outcome of treatment and identification of risk factors. <italic toggle="yes">J. Bone Jt. Surg.</italic><bold>98</bold>, 2082&#8211;2088 (2016).<pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.15.01450</pub-id><pub-id pub-id-type="pmid">28002371</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gil</surname><given-names>D</given-names></name><etal/></person-group><article-title>Addressing prosthetic joint infections via gentamicin-eluting UHMWPE spacer</article-title><source>Bone Jt. J.</source><year>2020</year><volume>102-B</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.102B6.BJJ-2019-1593.R1</pub-id><pub-id pub-id-type="pmid">32475290</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Gil, D. et al. Addressing prosthetic joint infections via gentamicin-eluting UHMWPE spacer. <italic toggle="yes">Bone Jt. J.</italic><bold>102-B</bold>, 151&#8211;157 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/0301-620X.102B6.BJJ-2019-1593.R1</pub-id><pub-id pub-id-type="pmid">32475290</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>H-M</given-names></name><etal/></person-group><article-title>Microbiology of periprosthetic hip and knee infections in surgically revised cases from 34 centers in Mainland China</article-title><source>Infect. Drug Resist</source><year>2021</year><volume>14</volume><fpage>2411</fpage><lpage>2418</lpage><pub-id pub-id-type="doi">10.2147/IDR.S305205</pub-id><pub-id pub-id-type="pmid">34211286</pub-id><pub-id pub-id-type="pmcid">PMC8241811</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Peng, H.-M. et al. Microbiology of periprosthetic hip and knee infections in surgically revised cases from 34 centers in Mainland China. <italic toggle="yes">Infect. Drug Resist</italic><bold>14</bold>, 2411&#8211;2418 (2021).<pub-id pub-id-type="pmid">34211286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IDR.S305205</pub-id><pub-id pub-id-type="pmcid">PMC8241811</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lories</surname><given-names>B</given-names></name><etal/></person-group><article-title>Biofilm bacteria use stress responses to detect and respond to competitors</article-title><source>Curr. Biol.</source><year>2020</year><volume>30</volume><fpage>1231</fpage><lpage>1244.e4</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2020.01.065</pub-id><pub-id pub-id-type="pmid">32084407</pub-id><pub-id pub-id-type="pmcid">PMC7322538</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Lories, B. et al. Biofilm bacteria use stress responses to detect and respond to competitors. <italic toggle="yes">Curr. Biol.</italic><bold>30</bold>, 1231&#8211;1244.e4 (2020).<pub-id pub-id-type="pmid">32084407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cub.2020.01.065</pub-id><pub-id pub-id-type="pmcid">PMC7322538</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anju</surname><given-names>VT</given-names></name><etal/></person-group><article-title>Polymicrobial infections and biofilms: Clinical significance and eradication strategies</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><fpage>1731</fpage><pub-id pub-id-type="doi">10.3390/antibiotics11121731</pub-id><pub-id pub-id-type="pmid">36551388</pub-id><pub-id pub-id-type="pmcid">PMC9774821</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Anju, V. T. et al. Polymicrobial infections and biofilms: Clinical significance and eradication strategies. <italic toggle="yes">Antibiotics</italic><bold>11</bold>, 1731 (2022).<pub-id pub-id-type="pmid">36551388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics11121731</pub-id><pub-id pub-id-type="pmcid">PMC9774821</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alves</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR</article-title><source>J. Biol. Chem.</source><year>2010</year><volume>285</volume><fpage>27536</fpage><lpage>27544</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.130955</pub-id><pub-id pub-id-type="pmid">20566635</pub-id><pub-id pub-id-type="pmcid">PMC2934620</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Alves, C. S. et al. Escherichia coli cell surface perturbation and disruption induced by antimicrobial peptides BP100 and pepR. <italic toggle="yes">J. Biol. Chem.</italic><bold>285</bold>, 27536&#8211;27544 (2010).<pub-id pub-id-type="pmid">20566635</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M110.130955</pub-id><pub-id pub-id-type="pmcid">PMC2934620</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alford</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mann</surname><given-names>S</given-names></name><name name-style="western"><surname>Akhoundsadegh</surname><given-names>N</given-names></name><name name-style="western"><surname>Hancock</surname><given-names>REW</given-names></name></person-group><article-title>Competition between Pseudomonas aeruginosa and Staphylococcus aureus is dependent on intercellular signaling and regulated by the NtrBC two-component system</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>9027</fpage><pub-id pub-id-type="doi">10.1038/s41598-022-12650-2</pub-id><pub-id pub-id-type="pmid">35637237</pub-id><pub-id pub-id-type="pmcid">PMC9150766</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Alford, M. A., Mann, S., Akhoundsadegh, N. &amp; Hancock, R. E. W. Competition between Pseudomonas aeruginosa and Staphylococcus aureus is dependent on intercellular signaling and regulated by the NtrBC two-component system. <italic toggle="yes">Sci. Rep.</italic><bold>12</bold>, 9027 (2022).<pub-id pub-id-type="pmid">35637237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-022-12650-2</pub-id><pub-id pub-id-type="pmcid">PMC9150766</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Escherichia coli BarA-UvrY regulates the pks island and kills Staphylococci via the genotoxin colibactin during interspecies competition</article-title><source>PLoS Pathog.</source><year>2022</year><volume>18</volume><fpage>e1010766</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1010766</pub-id><pub-id pub-id-type="pmid">36067266</pub-id><pub-id pub-id-type="pmcid">PMC9481169</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Wong, J. J. et al. Escherichia coli BarA-UvrY regulates the pks island and kills Staphylococci via the genotoxin colibactin during interspecies competition. <italic toggle="yes">PLoS Pathog.</italic><bold>18</bold>, e1010766 (2022).<pub-id pub-id-type="pmid">36067266</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1010766</pub-id><pub-id pub-id-type="pmcid">PMC9481169</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mariani</surname><given-names>F</given-names></name><name name-style="western"><surname>Galvan</surname><given-names>EM</given-names></name></person-group><article-title>Staphylococcus aureus in Polymicrobial Skinand Soft Tissue Infections: Impact of Inter-Species Interactionsin Disease Outcome</article-title><source>Antibiotics</source><year>2023</year><volume>12</volume><fpage>1164</fpage><pub-id pub-id-type="doi">10.3390/antibiotics12071164</pub-id><pub-id pub-id-type="pmid">37508260</pub-id><pub-id pub-id-type="pmcid">PMC10376372</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Mariani, F. &amp; Galvan, E. M. Staphylococcus aureus in Polymicrobial Skinand Soft Tissue Infections: Impact of Inter-Species Interactionsin Disease Outcome. <italic toggle="yes">Antibiotics</italic><bold>12</bold>, 1164 (2023).<pub-id pub-id-type="pmid">37508260</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics12071164</pub-id><pub-id pub-id-type="pmcid">PMC10376372</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaston</surname><given-names>JR</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>AO</given-names></name><name name-style="western"><surname>Bair</surname><given-names>KL</given-names></name><name name-style="western"><surname>White</surname><given-names>AN</given-names></name><name name-style="western"><surname>Armbruster</surname><given-names>CE</given-names></name></person-group><article-title>Polymicrobial interactions in the urinary tract: Is the enemy of my enemy my friend?</article-title><source>Infect Immun.</source><year>2021</year><volume>89</volume><fpage> iai.00652-20</fpage><pub-id pub-id-type="doi">10.1128/IAI.00652-20</pub-id><pub-id pub-id-type="pmid">33431702</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Gaston, J. R., Johnson, A. O., Bair, K. L., White, A. N. &amp; Armbruster, C. E. Polymicrobial interactions in the urinary tract: Is the enemy of my enemy my friend?. <italic toggle="yes">Infect Immun.</italic><bold>89</bold>, iai.00652-20 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00652-20</pub-id><pub-id pub-id-type="pmid">33431702</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kline</surname><given-names>KA</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>AL</given-names></name></person-group><article-title>Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract</article-title><source>Microbiol. Spectr.</source><year>2016</year><volume>4</volume><fpage>UTI-0012-2012</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.1128/microbiolspec.UTI-0012-2012</pub-id><pub-id pub-id-type="pmcid">PMC4888879</pub-id><pub-id pub-id-type="pmid">27227294</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Kline, K. A. &amp; Lewis, A. L. Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. <italic toggle="yes">Microbiol. Spectr.</italic><bold>4</bold>, UTI-0012-2012&#8211;2012 (2016).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/microbiolspec.UTI-0012-2012</pub-id><pub-id pub-id-type="pmcid">PMC4888879</pub-id><pub-id pub-id-type="pmid">27227294</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moriarty</surname><given-names>TF</given-names></name><etal/></person-group><article-title>The 2023 Orthopaedic Research Society International Consensus Meeting on musculoskeletal infection</article-title><source>J. Orthop. Res.</source><year>2024</year><volume>42</volume><fpage>497</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1002/jor.25714</pub-id><pub-id pub-id-type="pmid">37823833</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Moriarty, T. F. et al. The 2023 Orthopaedic Research Society International Consensus Meeting on musculoskeletal infection. <italic toggle="yes">J. Orthop. Res.</italic><bold>42</bold>, 497&#8211;499 (2024).<pub-id pub-id-type="pmid">37823833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jor.25714</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jennings</surname><given-names>JA</given-names></name><etal/></person-group><article-title>2023 International Consensus Meeting on musculoskeletal infection: Summary from the treatment workgroup and consensus on treatment in preclinical models</article-title><source>J. Orthop. Res.</source><year>2024</year><volume>42</volume><fpage>500</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1002/jor.25765</pub-id><pub-id pub-id-type="pmid">38069631</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Jennings, J. A. et al. 2023 International Consensus Meeting on musculoskeletal infection: Summary from the treatment workgroup and consensus on treatment in preclinical models. <italic toggle="yes">J. Orthop. Res.</italic><bold>42</bold>, 500&#8211;511 (2024).<pub-id pub-id-type="pmid">38069631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jor.25765</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarz</surname><given-names>EM</given-names></name><etal/></person-group><article-title>The 2023 Orthopaedic Research Society&#8217;s International Consensus Meeting on musculoskeletal infection: Summary from the host immunity section</article-title><source>J. Orthop. Res.</source><year>2024</year><volume>42</volume><fpage>518</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1002/jor.25758</pub-id><pub-id pub-id-type="pmid">38102985</pub-id><pub-id pub-id-type="pmcid">PMC10932846</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Schwarz, E. M. et al. The 2023 Orthopaedic Research Society&#8217;s International Consensus Meeting on musculoskeletal infection: Summary from the host immunity section. <italic toggle="yes">J. Orthop. Res.</italic><bold>42</bold>, 518&#8211;530 (2024).<pub-id pub-id-type="pmid">38102985</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jor.25758</pub-id><pub-id pub-id-type="pmcid">PMC10932846</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hickok</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>The 2023 Orthopedic Research Society&#8217;s international consensus meeting on musculoskeletal infection: Summary from the in vitro section</article-title><source>J. Orthop. Res.</source><year>2024</year><volume>42</volume><fpage>512</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1002/jor.25774</pub-id><pub-id pub-id-type="pmid">38146070</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Hickok, N. J. et al. The 2023 Orthopedic Research Society&#8217;s international consensus meeting on musculoskeletal infection: Summary from the in vitro section. <italic toggle="yes">J. Orthop. Res.</italic><bold>42</bold>, 512&#8211;517 (2024).<pub-id pub-id-type="pmid">38146070</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jor.25774</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kapadia</surname><given-names>BH</given-names></name><etal/></person-group><article-title>Periprosthetic joint infection</article-title><source>Lancet</source><year>2016</year><volume>387</volume><fpage>386</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(14)61798-0</pub-id><pub-id pub-id-type="pmid">26135702</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Kapadia, B. H. et al. Periprosthetic joint infection. <italic toggle="yes">Lancet</italic><bold>387</bold>, 386&#8211;394 (2016).<pub-id pub-id-type="pmid">26135702</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(14)61798-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carli</surname><given-names>AV</given-names></name><etal/></person-group><article-title>Quantification of peri-implant bacterial load and in vivo biofilm formation in an innovative, clinically representative mouse model of periprosthetic joint infection</article-title><source>J. Bone Jt. Surg.</source><year>2017</year><volume>99</volume><fpage>e25</fpage><pub-id pub-id-type="doi">10.2106/JBJS.16.00815</pub-id><pub-id pub-id-type="pmid">28291188</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Carli, A. V. et al. Quantification of peri-implant bacterial load and in vivo biofilm formation in an innovative, clinically representative mouse model of periprosthetic joint infection. <italic toggle="yes">J. Bone Jt. Surg.</italic><bold>99</bold>, e25 (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.16.00815</pub-id><pub-id pub-id-type="pmid">28291188</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poilvache</surname><given-names>H</given-names></name><name name-style="western"><surname>Van Bambeke</surname><given-names>F</given-names></name><name name-style="western"><surname>Cornu</surname><given-names>O</given-names></name></person-group><article-title>Development of an innovative in vivo model of PJI treated with DAIR</article-title><source>Front Med (Lausanne)</source><year>2022</year><volume>9</volume><fpage>984814</fpage><pub-id pub-id-type="doi">10.3389/fmed.2022.984814</pub-id><pub-id pub-id-type="pmid">36314026</pub-id><pub-id pub-id-type="pmcid">PMC9606572</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Poilvache, H., Van Bambeke, F. &amp; Cornu, O. Development of an innovative in vivo model of PJI treated with DAIR. <italic toggle="yes">Front Med (Lausanne)</italic><bold>9</bold>, 984814 (2022).<pub-id pub-id-type="pmid">36314026</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2022.984814</pub-id><pub-id pub-id-type="pmcid">PMC9606572</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">Fan Y. et al. Immune response against antibiotic-resistant and antibiotic-sensitive staphylococcus aureus in a rat model of implant infection. in (Orthopaedic Research Society, Long Beach, 2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-025-95004-y</pub-id><pub-id pub-id-type="pmcid">PMC12006483</pub-id><pub-id pub-id-type="pmid">40246912</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sekar</surname><given-names>A</given-names></name><etal/></person-group><article-title>Synergistic use of anti-inflammatory ketorolac and gentamicin to target staphylococcal biofilms</article-title><source>J. Transl. Med</source><year>2024</year><volume>22</volume><fpage>102</fpage><pub-id pub-id-type="doi">10.1186/s12967-024-04871-y</pub-id><pub-id pub-id-type="pmid">38273276</pub-id><pub-id pub-id-type="pmcid">PMC10809490</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Sekar, A. et al. Synergistic use of anti-inflammatory ketorolac and gentamicin to target staphylococcal biofilms. <italic toggle="yes">J. Transl. Med</italic>. <bold>22</bold>, 102 (2024).<pub-id pub-id-type="pmid">38273276</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12967-024-04871-y</pub-id><pub-id pub-id-type="pmcid">PMC10809490</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>C</given-names></name><etal/></person-group><article-title>Escherichia coli exopolysaccharides disrupt Pseudomonas aeruginosa biofilm and increase its antibiotic susceptibility</article-title><source>Acta Biomater.</source><year>2024</year><volume>185</volume><fpage>215</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2024.07.028</pub-id><pub-id pub-id-type="pmid">39067645</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Wan, C. et al. Escherichia coli exopolysaccharides disrupt Pseudomonas aeruginosa biofilm and increase its antibiotic susceptibility. <italic toggle="yes">Acta Biomater.</italic><bold>185</bold>, 215&#8211;225 (2024).<pub-id pub-id-type="pmid">39067645</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2024.07.028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eberl</surname><given-names>C</given-names></name><etal/></person-group><article-title>E. coli enhance colonization resistance against Salmonella Typhimurium by competing for galactitol, a context-dependent limiting carbon source</article-title><source>Cell Host Microbe</source><year>2021</year><volume>29</volume><fpage>1680</fpage><lpage>1692.e7</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2021.09.004</pub-id><pub-id pub-id-type="pmid">34610296</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Eberl, C. et al. E. coli enhance colonization resistance against Salmonella Typhimurium by competing for galactitol, a context-dependent limiting carbon source. <italic toggle="yes">Cell Host Microbe</italic><bold>29</bold>, 1680&#8211;1692.e7 (2021).<pub-id pub-id-type="pmid">34610296</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2021.09.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kastrat</surname><given-names>E</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>H-P</given-names></name></person-group><article-title>Escherichia coli has an undiscovered ability to inhibit the growth of both Gram-negative and Gram-positive bacteria</article-title><source>Sci. Rep.</source><year>2024</year><volume>14</volume><fpage>7420</fpage><pub-id pub-id-type="doi">10.1038/s41598-024-57996-x</pub-id><pub-id pub-id-type="pmid">38548840</pub-id><pub-id pub-id-type="pmcid">PMC10978900</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Kastrat, E. &amp; Cheng, H.-P. Escherichia coli has an undiscovered ability to inhibit the growth of both Gram-negative and Gram-positive bacteria. <italic toggle="yes">Sci. Rep.</italic><bold>14</bold>, 7420 (2024).<pub-id pub-id-type="pmid">38548840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-024-57996-x</pub-id><pub-id pub-id-type="pmcid">PMC10978900</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><name name-style="western"><surname>Ray</surname><given-names>P</given-names></name><name name-style="western"><surname>Das</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>M</given-names></name></person-group><article-title>Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study</article-title><source>J. Med. Microbiol</source><year>2009</year><volume>58</volume><fpage>1067</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.009720-0</pub-id><pub-id pub-id-type="pmid">19528167</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Singh, R., Ray, P., Das, A. &amp; Sharma, M. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. <italic toggle="yes">J. Med. Microbiol</italic><bold>58</bold>, 1067&#8211;1073 (2009).<pub-id pub-id-type="pmid">19528167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/jmm.0.009720-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keim</surname><given-names>KC</given-names></name><name name-style="western"><surname>George</surname><given-names>IK</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>L</given-names></name><name name-style="western"><surname>Clinton Smith</surname><given-names>A</given-names></name></person-group><article-title>The clinical significance of <italic toggle="yes">Staphylococcus aureus</italic> small colony variants</article-title><source>Am. Soc. Clin. Lab. Sci.</source><year>2021</year><volume>34</volume><fpage>32</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.29074/ascls.2020002691</pub-id><pub-id pub-id-type="pmid">36226897</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Keim, K. C., George, I. K., Reynolds, L. &amp; Clinton Smith, A. The clinical significance of <italic toggle="yes">Staphylococcus aureus</italic> small colony variants. <italic toggle="yes">Am. Soc. Clin. Lab. Sci.</italic><bold>34</bold>, 32&#8211;41 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/labmed/lmac101</pub-id><pub-id pub-id-type="pmid">36226897</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kenny</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Mannitol utilisation is required for protection of staphylococcus aureus from human skin antimicrobial fatty acids</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e67698</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0067698</pub-id><pub-id pub-id-type="pmid">23861785</pub-id><pub-id pub-id-type="pmcid">PMC3701532</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Kenny, J. G. et al. Mannitol utilisation is required for protection of staphylococcus aureus from human skin antimicrobial fatty acids. <italic toggle="yes">PLoS One</italic><bold>8</bold>, e67698 (2013).<pub-id pub-id-type="pmid">23861785</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0067698</pub-id><pub-id pub-id-type="pmcid">PMC3701532</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loss</surname><given-names>G</given-names></name><etal/></person-group><article-title>Staphylococcus aureus Small Colony Variants (SCVs): News From a Chronic Prosthetic Joint Infection</article-title><source>Front Cell Infect Microbiol</source><year>2019</year><volume>9</volume><fpage>363</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2019.00363</pub-id><pub-id pub-id-type="pmid">31696062</pub-id><pub-id pub-id-type="pmcid">PMC6817495</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Loss, G. et al. Staphylococcus aureus Small Colony Variants (SCVs): News From a Chronic Prosthetic Joint Infection. <italic toggle="yes">Front Cell Infect Microbiol</italic><bold>9</bold>, 363 (2019).<pub-id pub-id-type="pmid">31696062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2019.00363</pub-id><pub-id pub-id-type="pmcid">PMC6817495</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Proctor</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections</article-title><source>Front Cell Infect Microbiol</source><year>2014</year><volume>4</volume><fpage>99</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2014.00099</pub-id><pub-id pub-id-type="pmid">25120957</pub-id><pub-id pub-id-type="pmcid">PMC4112797</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Proctor, R. A. et al. Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections. <italic toggle="yes">Front Cell Infect Microbiol</italic><bold>4</bold>, 99 (2014).<pub-id pub-id-type="pmid">25120957</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2014.00099</pub-id><pub-id pub-id-type="pmcid">PMC4112797</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bottura</surname><given-names>B</given-names></name><name name-style="western"><surname>Rooney</surname><given-names>LM</given-names></name><name name-style="western"><surname>Hoskisson</surname><given-names>PA</given-names></name><name name-style="western"><surname>McConnell</surname><given-names>G</given-names></name></person-group><article-title>Intra-colony channel morphology in Escherichia coli biofilms is governed by nutrient availability and substrate stiffness</article-title><source>Biofilm</source><year>2022</year><volume>4</volume><fpage>100084</fpage><pub-id pub-id-type="doi">10.1016/j.bioflm.2022.100084</pub-id><pub-id pub-id-type="pmid">36254115</pub-id><pub-id pub-id-type="pmcid">PMC9568850</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Bottura, B., Rooney, L. M., Hoskisson, P. A. &amp; McConnell, G. Intra-colony channel morphology in Escherichia coli biofilms is governed by nutrient availability and substrate stiffness. <italic toggle="yes">Biofilm</italic><bold>4</bold>, 100084 (2022).<pub-id pub-id-type="pmid">36254115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioflm.2022.100084</pub-id><pub-id pub-id-type="pmcid">PMC9568850</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siri</surname><given-names>M</given-names></name><name name-style="western"><surname>V&#225;zquez-D&#225;vila</surname><given-names>M</given-names></name><name name-style="western"><surname>Sotelo Guzman</surname><given-names>C</given-names></name><name name-style="western"><surname>Bidan</surname><given-names>CM</given-names></name></person-group><article-title>Nutrient availability influences E. coli biofilm properties and the structure of purified curli amyloid fibers</article-title><source>NPJ Biofilms Microbiomes</source><year>2024</year><volume>10</volume><fpage>143</fpage><pub-id pub-id-type="doi">10.1038/s41522-024-00619-0</pub-id><pub-id pub-id-type="pmid">39632887</pub-id><pub-id pub-id-type="pmcid">PMC11618413</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Siri, M., V&#225;zquez-D&#225;vila, M., Sotelo Guzman, C. &amp; Bidan, C. M. Nutrient availability influences E. coli biofilm properties and the structure of purified curli amyloid fibers. <italic toggle="yes">NPJ Biofilms Microbiomes</italic><bold>10</bold>, 143 (2024).<pub-id pub-id-type="pmid">39632887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41522-024-00619-0</pub-id><pub-id pub-id-type="pmcid">PMC11618413</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milho</surname><given-names>C</given-names></name><etal/></person-group><article-title>Escherichia coli and Salmonella Enteritidis dual-species biofilms: interspecies interactions and antibiofilm efficacy of phages</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>18183</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-54847-y</pub-id><pub-id pub-id-type="pmid">31796870</pub-id><pub-id pub-id-type="pmcid">PMC6890764</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Milho, C. et al. Escherichia coli and Salmonella Enteritidis dual-species biofilms: interspecies interactions and antibiofilm efficacy of phages. <italic toggle="yes">Sci. Rep.</italic><bold>9</bold>, 18183 (2019).<pub-id pub-id-type="pmid">31796870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-54847-y</pub-id><pub-id pub-id-type="pmcid">PMC6890764</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>K</given-names></name><etal/></person-group><article-title>Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters</article-title><source>Sci. Rep.</source><year>2025</year><volume>15</volume><fpage>3739</fpage><pub-id pub-id-type="doi">10.1038/s41598-024-81953-3</pub-id><pub-id pub-id-type="pmid">39885187</pub-id><pub-id pub-id-type="pmcid">PMC11782587</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Sung, K. et al. Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters. <italic toggle="yes">Sci. Rep.</italic><bold>15</bold>, 3739 (2025).<pub-id pub-id-type="pmid">39885187</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-024-81953-3</pub-id><pub-id pub-id-type="pmcid">PMC11782587</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kjellin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Colicins and T6SS-based competition systems enhance enterotoxigenic <italic toggle="yes">E. coli</italic> (ETEC) competitiveness</article-title><source>Gut Microbes</source><year>2024</year><volume>16</volume><fpage>2295891</fpage><pub-id pub-id-type="doi">10.1080/19490976.2023.2295891</pub-id><pub-id pub-id-type="pmid">38149626</pub-id><pub-id pub-id-type="pmcid">PMC10761095</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Kjellin, J. et al. Colicins and T6SS-based competition systems enhance enterotoxigenic <italic toggle="yes">E. coli</italic> (ETEC) competitiveness. <italic toggle="yes">Gut Microbes</italic><bold>16</bold>, 2295891 (2024).<pub-id pub-id-type="pmid">38149626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/19490976.2023.2295891</pub-id><pub-id pub-id-type="pmcid">PMC10761095</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kommineni</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract</article-title><source>Nature</source><year>2015</year><volume>526</volume><fpage>719</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1038/nature15524</pub-id><pub-id pub-id-type="pmid">26479034</pub-id><pub-id pub-id-type="pmcid">PMC4978352</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Kommineni, S. et al. Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. <italic toggle="yes">Nature</italic><bold>526</bold>, 719&#8211;722 (2015).<pub-id pub-id-type="pmid">26479034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature15524</pub-id><pub-id pub-id-type="pmcid">PMC4978352</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cirilli</surname><given-names>N</given-names></name><etal/></person-group><article-title>Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy</article-title><source>J. Cyst. Fibros.</source><year>2024</year><volume>23</volume><fpage>1153</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1016/j.jcf.2024.02.013</pub-id><pub-id pub-id-type="pmid">38423895</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Cirilli, N. et al. Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy. <italic toggle="yes">J. Cyst. Fibros.</italic><bold>23</bold>, 1153&#8211;1158 (2024).<pub-id pub-id-type="pmid">38423895</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcf.2024.02.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hung</surname><given-names>C</given-names></name><etal/></person-group><article-title>Escherichia coli biofilms have an organized and complex extracellular matrix structure</article-title><source>mBio</source><year>2013</year><volume>4</volume><fpage>e00645</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1128/mBio.00645-13</pub-id><pub-id pub-id-type="pmid">24023384</pub-id><pub-id pub-id-type="pmcid">PMC3774191</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Hung, C. et al. Escherichia coli biofilms have an organized and complex extracellular matrix structure. <italic toggle="yes">mBio</italic><bold>4</bold>, e00645&#8211;13 (2013).<pub-id pub-id-type="pmid">24023384</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mBio.00645-13</pub-id><pub-id pub-id-type="pmcid">PMC3774191</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>D</given-names></name><etal/></person-group><article-title>The Production of Curli Amyloid Fibers Is Deeply Integrated into the Biology of Escherichia coli</article-title><source>Biomolecules</source><year>2017</year><volume>7</volume><fpage>75</fpage><pub-id pub-id-type="doi">10.3390/biom7040075</pub-id><pub-id pub-id-type="pmid">29088115</pub-id><pub-id pub-id-type="pmcid">PMC5745457</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Smith, D. et al. The Production of Curli Amyloid Fibers Is Deeply Integrated into the Biology of Escherichia coli. <italic toggle="yes">Biomolecules</italic><bold>7</bold>, 75 (2017).<pub-id pub-id-type="pmid">29088115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biom7040075</pub-id><pub-id pub-id-type="pmcid">PMC5745457</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lories</surname><given-names>B</given-names></name><name name-style="western"><surname>Belpaire</surname><given-names>TER</given-names></name><name name-style="western"><surname>Smeets</surname><given-names>B</given-names></name><name name-style="western"><surname>Steenackers</surname><given-names>HP</given-names></name></person-group><article-title>Competition quenching strategies reduce antibiotic tolerance in polymicrobial biofilms</article-title><source>NPJ Biofilms Microbiomes</source><year>2024</year><volume>10</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1038/s41522-024-00489-6</pub-id><pub-id pub-id-type="pmid">38503782</pub-id><pub-id pub-id-type="pmcid">PMC10951329</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Lories, B., Belpaire, T. E. R., Smeets, B. &amp; Steenackers, H. P. Competition quenching strategies reduce antibiotic tolerance in polymicrobial biofilms. <italic toggle="yes">NPJ Biofilms Microbiomes</italic><bold>10</bold>, 23 (2024).<pub-id pub-id-type="pmid">38503782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41522-024-00489-6</pub-id><pub-id pub-id-type="pmcid">PMC10951329</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otto</surname><given-names>M</given-names></name></person-group><article-title>Staphylococcal Biofilms</article-title><source>Microbiol Spectr</source><year>2018</year><volume>6</volume><fpage>gpp3-0023-2018</fpage><pub-id pub-id-type="doi">10.1128/microbiolspec.GPP3-0023-2018</pub-id><pub-id pub-id-type="pmcid">PMC6282163</pub-id><pub-id pub-id-type="pmid">30117414</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Otto, M. Staphylococcal Biofilms. <italic toggle="yes">Microbiol Spectr</italic><bold>6</bold>, gpp3-0023-2018 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/microbiolspec.gpp3-0023-2018</pub-id><pub-id pub-id-type="pmcid">PMC6282163</pub-id><pub-id pub-id-type="pmid">30117414</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mah</surname><given-names>T-FC</given-names></name><name name-style="western"><surname>O&#8217;Toole</surname><given-names>GA</given-names></name></person-group><article-title>Mechanisms of biofilm resistance to antimicrobial agents</article-title><source>Trends Microbiol</source><year>2001</year><volume>9</volume><fpage>34</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/S0966-842X(00)01913-2</pub-id><pub-id pub-id-type="pmid">11166241</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Mah, T.-F. C. &amp; O&#8217;Toole, G. A. Mechanisms of biofilm resistance to antimicrobial agents. <italic toggle="yes">Trends Microbiol</italic><bold>9</bold>, 34&#8211;39 (2001).<pub-id pub-id-type="pmid">11166241</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0966-842x(00)01913-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Staphylococcus aureus biofilm: Formulation, regulatory, and emerging natural products-derived therapeutics</article-title><source>Biofilm</source><year>2024</year><volume>7</volume><fpage>100175</fpage><pub-id pub-id-type="doi">10.1016/j.bioflm.2023.100175</pub-id><pub-id pub-id-type="pmid">38298832</pub-id><pub-id pub-id-type="pmcid">PMC10827693</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Wu, X. et al. Staphylococcus aureus biofilm: Formulation, regulatory, and emerging natural products-derived therapeutics. <italic toggle="yes">Biofilm</italic><bold>7</bold>, 100175 (2024).<pub-id pub-id-type="pmid">38298832</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioflm.2023.100175</pub-id><pub-id pub-id-type="pmcid">PMC10827693</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballal</surname><given-names>A</given-names></name><name name-style="western"><surname>Manna</surname><given-names>AC</given-names></name></person-group><article-title>Regulation of Superoxide Dismutase (<italic toggle="yes">sod</italic>) Genes by SarA in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J. Bacteriol.</source><year>2009</year><volume>191</volume><fpage>3301</fpage><lpage>3310</lpage><pub-id pub-id-type="doi">10.1128/JB.01496-08</pub-id><pub-id pub-id-type="pmid">19286803</pub-id><pub-id pub-id-type="pmcid">PMC2687179</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Ballal, A. &amp; Manna, A. C. Regulation of Superoxide Dismutase (<italic toggle="yes">sod</italic>) Genes by SarA in <italic toggle="yes">Staphylococcus aureus</italic>. <italic toggle="yes">J. Bacteriol.</italic><bold>191</bold>, 3301&#8211;3310 (2009).<pub-id pub-id-type="pmid">19286803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.01496-08</pub-id><pub-id pub-id-type="pmcid">PMC2687179</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vijayakumar</surname><given-names>SRV</given-names></name><name name-style="western"><surname>Kirchhof</surname><given-names>MG</given-names></name><name name-style="western"><surname>Patten</surname><given-names>CL</given-names></name><name name-style="western"><surname>Schellhorn</surname><given-names>HE</given-names></name></person-group><article-title>RpoS-Regulated Genes of <italic toggle="yes">Escherichia coli</italic> Identified by Random <italic toggle="yes">lacZ</italic> Fusion Mutagenesis</article-title><source>J. Bacteriol.</source><year>2004</year><volume>186</volume><fpage>8499</fpage><lpage>8507</lpage><pub-id pub-id-type="doi">10.1128/JB.186.24.8499-8507.2004</pub-id><pub-id pub-id-type="pmid">15576800</pub-id><pub-id pub-id-type="pmcid">PMC532425</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Vijayakumar, S. R. V., Kirchhof, M. G., Patten, C. L. &amp; Schellhorn, H. E. RpoS-Regulated Genes of <italic toggle="yes">Escherichia coli</italic> Identified by Random <italic toggle="yes">lacZ</italic> Fusion Mutagenesis. <italic toggle="yes">J. Bacteriol.</italic><bold>186</bold>, 8499&#8211;8507 (2004).<pub-id pub-id-type="pmid">15576800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.186.24.8499-8507.2004</pub-id><pub-id pub-id-type="pmcid">PMC532425</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nougayr&#232;de</surname><given-names>J-P</given-names></name><etal/></person-group><article-title><italic toggle="yes">Escherichia coli</italic> Induces DNA double-strand breaks in eukaryotic cells</article-title><source>Science (1979)</source><year>2006</year><volume>313</volume><fpage>848</fpage><lpage>851</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1127059</pub-id><pub-id pub-id-type="pmid">16902142</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Nougayr&#232;de, J.-P. et al. <italic toggle="yes">Escherichia coli</italic> Induces DNA double-strand breaks in eukaryotic cells. <italic toggle="yes">Science (1979)</italic><bold>313</bold>, 848&#8211;851 (2006).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1127059</pub-id><pub-id pub-id-type="pmid">16902142</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X-S</given-names></name><name name-style="western"><surname>Wood</surname><given-names>TK</given-names></name></person-group><article-title>Toxin-antitoxin systems in <italic toggle="yes">Escherichia coli</italic> Influence Biofilm Formation through YjgK (TabA) and Fimbriae</article-title><source>J. Bacteriol.</source><year>2009</year><volume>191</volume><fpage>1258</fpage><lpage>1267</lpage><pub-id pub-id-type="doi">10.1128/JB.01465-08</pub-id><pub-id pub-id-type="pmid">19060153</pub-id><pub-id pub-id-type="pmcid">PMC2632003</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Kim, Y., Wang, X., Ma, Q., Zhang, X.-S. &amp; Wood, T. K. Toxin-antitoxin systems in <italic toggle="yes">Escherichia coli</italic> Influence Biofilm Formation through YjgK (TabA) and Fimbriae. <italic toggle="yes">J. Bacteriol.</italic><bold>191</bold>, 1258&#8211;1267 (2009).<pub-id pub-id-type="pmid">19060153</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.01465-08</pub-id><pub-id pub-id-type="pmcid">PMC2632003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodille</surname><given-names>E</given-names></name><etal/></person-group><article-title>The role of antibiotics in modulating virulence in staphylococcus aureus</article-title><source>Clin. Microbiol Rev.</source><year>2017</year><volume>30</volume><fpage>887</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1128/CMR.00120-16</pub-id><pub-id pub-id-type="pmid">28724662</pub-id><pub-id pub-id-type="pmcid">PMC5608880</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Hodille, E. et al. The role of antibiotics in modulating virulence in staphylococcus aureus. <italic toggle="yes">Clin. Microbiol Rev.</italic><bold>30</bold>, 887&#8211;917 (2017).<pub-id pub-id-type="pmid">28724662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CMR.00120-16</pub-id><pub-id pub-id-type="pmcid">PMC5608880</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ciofu</surname><given-names>O</given-names></name><name name-style="western"><surname>Rojo-Molinero</surname><given-names>E</given-names></name><name name-style="western"><surname>Maci&#224;</surname><given-names>MD</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>A</given-names></name></person-group><article-title>Antibiotic treatment of biofilm infections</article-title><source>APMIS</source><year>2017</year><volume>125</volume><fpage>304</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1111/apm.12673</pub-id><pub-id pub-id-type="pmid">28407419</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Ciofu, O., Rojo-Molinero, E., Maci&#224;, M. D. &amp; Oliver, A. Antibiotic treatment of biofilm infections. <italic toggle="yes">APMIS</italic><bold>125</bold>, 304&#8211;319 (2017).<pub-id pub-id-type="pmid">28407419</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/apm.12673</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Bleeckere</surname><given-names>A</given-names></name><etal/></person-group><article-title>A novel synthetic synovial fluid model for investigating biofilm formation and antibiotic susceptibility in prosthetic joint infections</article-title><source>Microbiol Spectr</source><year>2025</year><volume>13</volume><fpage>e0198024</fpage><pub-id pub-id-type="doi">10.1128/spectrum.01980-24</pub-id><pub-id pub-id-type="pmid">39612218</pub-id><pub-id pub-id-type="pmcid">PMC11705890</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">De Bleeckere, A. et al. A novel synthetic synovial fluid model for investigating biofilm formation and antibiotic susceptibility in prosthetic joint infections. <italic toggle="yes">Microbiol Spectr</italic><bold>13</bold>, e0198024 (2025).<pub-id pub-id-type="pmid">39612218</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/spectrum.01980-24</pub-id><pub-id pub-id-type="pmcid">PMC11705890</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steixner</surname><given-names>SJM</given-names></name><etal/></person-group><article-title>Influence of nutrient media compared to human synovial fluid on the antibiotic susceptibility and biofilm gene expression of coagulase-negative staphylococci in vitro</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><fpage>790</fpage><pub-id pub-id-type="doi">10.3390/antibiotics10070790</pub-id><pub-id pub-id-type="pmid">34209737</pub-id><pub-id pub-id-type="pmcid">PMC8300679</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Steixner, S. J. M. et al. Influence of nutrient media compared to human synovial fluid on the antibiotic susceptibility and biofilm gene expression of coagulase-negative staphylococci in vitro. <italic toggle="yes">Antibiotics</italic><bold>10</bold>, 790 (2021).<pub-id pub-id-type="pmid">34209737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics10070790</pub-id><pub-id pub-id-type="pmcid">PMC8300679</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zimmerli</surname><given-names>W</given-names></name><name name-style="western"><surname>Waldvogel</surname><given-names>FA</given-names></name><name name-style="western"><surname>Vaudaux</surname><given-names>P</given-names></name><name name-style="western"><surname>Nydegger</surname><given-names>UE</given-names></name></person-group><article-title>Pathogenesis of foreign body infection: Description and characteristics of an animal model</article-title><source>J. Infect. Dis.</source><year>1982</year><volume>146</volume><fpage>487</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1093/infdis/146.4.487</pub-id><pub-id pub-id-type="pmid">7119479</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Zimmerli, W., Waldvogel, F. A., Vaudaux, P. &amp; Nydegger, U. E. Pathogenesis of foreign body infection: Description and characteristics of an animal model. <italic toggle="yes">J. Infect. Dis.</italic><bold>146</bold>, 487&#8211;497 (1982).<pub-id pub-id-type="pmid">7119479</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/146.4.487</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lekkala</surname><given-names>S</given-names></name><etal/></person-group><article-title>Antibiotic-loaded ultrahigh molecular weight polyethylenes</article-title><source>Macromol Biosci</source><year>2024</year><volume>24</volume><fpage>e2300389</fpage><pub-id pub-id-type="doi">10.1002/mabi.202300389</pub-id><pub-id pub-id-type="pmid">38095273</pub-id><pub-id pub-id-type="pmcid">PMC11018474</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Lekkala, S. et al. Antibiotic-loaded ultrahigh molecular weight polyethylenes. <italic toggle="yes">Macromol Biosci</italic><bold>24</bold>, e2300389 (2024).<pub-id pub-id-type="pmid">38095273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mabi.202300389</pub-id><pub-id pub-id-type="pmcid">PMC11018474</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mountcastle</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Biofilm viability checker: An open-source tool for automated biofilm viability analysis from confocal microscopy images</article-title><source>NPJ Biofilms Microbiomes</source><year>2021</year><volume>7</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1038/s41522-021-00214-7</pub-id><pub-id pub-id-type="pmid">33990612</pub-id><pub-id pub-id-type="pmcid">PMC8121819</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Mountcastle, S. E. et al. Biofilm viability checker: An open-source tool for automated biofilm viability analysis from confocal microscopy images. <italic toggle="yes">NPJ Biofilms Microbiomes</italic><bold>7</bold>, 44 (2021).<pub-id pub-id-type="pmid">33990612</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41522-021-00214-7</pub-id><pub-id pub-id-type="pmcid">PMC8121819</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>